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V(D)J recombination is initiated by the RAG recombinase; a heterotetrameric complex 
consisting of two RAG-1 and two RAG-2 subunits.  The susceptibility of gene segments 
to cleavage by RAG is associated with histone modifications characteristic of active 
chromatin, including pan histone acetylation, and trimethylation of histone H3 at lysine 4 
(H3K4me3).  Binding of H3K4me3 by a plant homeodomain (PHD) in RAG-2 stimulates 
both DNA substrate binding and catalysis of the RAG-1 subunit. This has suggested an 
allosteric mechanism in which information regarding occupancy of the RAG-2 PHD is 
transmitted to RAG-1, thereby altering RAG-1’s activity.  To determine whether the 
conformational distribution of RAG is altered by H3K4me3, we mapped changes in 
solvent accessibility of cysteine thiols by differential isotopic chemical footprinting using 
tandem liquid chromatography mass spectrometry.  Binding of H3K4me3 to the RAG-2 
PHD induces conformational changes in RAG-1 within the DNA-binding domains and in 
the ZnH2 domain, which acts as a scaffold for the catalytic center.  These conformational 
changes are dependent on an intact PHD finger: mutation of tryptophan W453 in RAG-2 
to alanine disrupts the RAG-2 PHD-H3K4me3 interacton, and renders RAG-2 unable to 
stimulate conformational changes in RAG-1. Thus, engagement of H3K4me3 by an intact 
RAG-2 PHD is associated with dynamic conformational changes in RAG-1, consistent 
with allosteric control by active chromatin. To reveal the interface through which RAG-2 
transmits this allosteric signal to RAG-1, we generate chimeric murine RAG-2 proteins 
bearing plant homeodomains derived from distantly related shark RAG-2 PHD fingers. 
One of these chimeric RAG-2 proteins, bearing a PHD finger derived from C. punctatum, 
exhibits a loss of function similar to W453A, but retained the ability to bind H3K4me3. 
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Selective reversion of amino acid residues 417 through 433 in the C. punctatum PHD 
finger back to murine sequence was sufficient to rescue the W453A-like phenotype, 
indicating the allosteric transmission interface lies within this region of RAG-2. These 
data support a model where RAG-2 engagement of H3K4me3 produces conformational 
changes within the surface of the RAG-2 PHD finger, which in turn directly stimulate the 
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V(D)J recombination and the immune system 
The human body is challenged by thousands of viruses, bacteria, and other 
potential pathogens every day. To prevent and eliminate infections, the immune system 
must have a means of recognizing these foreign invaders. Recognition of foreign agents 
is achieved through the production of antigen receptors, such as immunoglobulins. These 
antigen receptors can recognize almost any foreign antigen the body encounters, 
stimulating the immune system to seek out and destroy these potential pathogens.  
In immature lymphocytes, antigen receptor genes are encoded as discreet, non-
contiguous gene segments, known as the Variable (V), Diversity (D), and Joining (J) 
segments. To form a functional antigen receptor gene, these gene segments must be 
assembled through a specialized form of DNA recombination called V(D)J 
recombination. V(D)J recombination is initiated by the recombination activating genes, 
RAG-1 and RAG-2, which form a heterotetrameric recombinase complex known as the 
RAG recombinase (RAG). RAG induces double strand breaks at recombination signal 
sequences (RSSs) which flank the V, D, and J segments (Schatz and Swanson 2011). 
These double strand breaks are then resolved by the non-homologous end joining (NHEJ) 
pathway, which join the gene segments together to form a functional antigen receptor. 
Each V, D, and J gene segment family has multiple members, all of which can be joined 
with members of the other families to produce an extraordinary number (3×1011) of V-D-
J combinations. This immense diversity is what allows the immune system to generate 
antigen receptors that recognize nearly any epitope.  
The two ultimate protein products of V(D)J recombination assembled antigen 
receptors, are antibodies and T cell receptors. Antibodies composed of two “heavy chain” 
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polypeptides, and two “light chain” polypeptides, which are encoded at the 
immunoglobulin heavy chain locus (IgH) and the immunoglobulin κ or λ loci 
respectively. These four peptides are assembled in a “Y” shaped structure, which is 
stabilized by disulfide bonds that connect the heavy and light chains together. T-cell 
receptors are encoded by the TCR α and β, or γ and δ loci; polypeptides generated from 
these loci form a heterodimer of either α and β peptides, or γ and δ peptides. These 
heterodimers exhibit disulfide linkages similar to antibodies, and are expressed as 
membrane anchored proteins on the surface of T-cells.  
Because RAG is an endonuclease, its activity must be carefully controlled to 
prevent the generation of off-target DNA double strand breaks, which can lead to 
oncogenic genomic lesions. There are multiple levels of control imparted on RAG by the 
cells in which it is expressed. For example, V(D)J recombination is cell lineage specific: 
in developing B cells, only immunoglobulin genes are rearranged, while the T Cell 
Receptor (TCR) remains silent, whereas in immature T Cells, the TCR is recombined 
while the immunoglobulin genes remain unrearranged (Schatz and Ji 2011). Despite the 
potential oncogenicity of RAG, its activity is essential to healthy immune function. 
Inactivating mutations of either subunits of RAG result in severe combined 
immunodeficiency (SCID); that is the inability to generate B or T cells. Patients with this 






The recombination activating genes RAG-1 and RAG-2  
 The RAG recombinase is a heterotetramer of the RAG-1 and RAG-2 proteins, 
which are 1040 and 527 amino acids long, respectively. Each protein is delineated by a 
“core” domain, and one or more “non-core” domains: the core domains are the minimal 
protein fragments which will support DNA cleavage in vitro, while the non-core domains 
contain regulatory elements which regulate the activity of the RAG protein complex.  
RAG-1  
The RAG-1 core domain is composed of seven distinct domains: an N-terminal 
nonamer binding domain (NBD) is connected to a Dimerization and DNA Binding 
Domain (DDBD) by a flexible linker (Fig1A). The DDBD in turn connects to a Pre-
RNASE H (PRER) and RNASE H fold (RNH), that comprise the catatlytic site of RAG-1 
where DNA cleavage occurs (Kim 2015). The two RAG-1 active sites within the tetramer 
are spaced ~45 angstroms apart in three-dimensional space. Beyond the RNASE H 
catalytic fold are the ZnC2 and ZnH2 domains, which form a zinc binding site, an 
interface for binding to RAG-2, and a portion of the DNA binding domain (Kim 2015).  
The uncrystallized N-terminal non-core domain of RAG-1 contains a RING domain of 
unclear function, which is dispensable for recombination (Yurchenko 2003). However, 
the RING domain has demonstrated autoubiquitilation activity, which may regulate the 







 In RAG-2, the core domain comprising residues 1-352 is structured into a six-
bladed β propeller, composed of six individual kelch domain repeats (Kim 2015). These 
kelch domains make direct contact with RAG-1, and are thought to contribute to DNA 
binding (Kim 2015, Ru 2015). Mutations within core RAG-2 have been identified that 
impair recombination activity (Qui 2001): these mutations either disrupt contacts between 
RAG-1 and RAG-2, or ablate RAG-2 contacts with DNA within the active site (Kim 
2015). The non-core region of RAG-2, comprising residues 352-521, is dispensable for 
RAG mediated DNA cleavage in vitro (Silver 1993, Liang 2002). However, removal of 
this non-core region disrupts endogenous recombination and dysregulates RAG 
expression in lymphocytes (Liang 2002, Mijuskovic 2015). Several important regulatory 
domains have been identified in RAG-2, including an autoinhibitory domain (residues 
352-405), a plant homeodomain (PHD) finger (residues 405-487), and a cell cycle 
regulatory site (T490) (Fig 1B). The autoinhibitory domain, described in detail in other 
publications from our lab (Lu 2007, Ward unpublished data) is thought to be an 
unstructured loop that is highly negatively charged due to high glutamate and aspartate 
composition. Mutation of the acidic residues in this domain rendered RAG “hyperactive”, 
enhancing both the catalytic rate and binding affinity of RAG (Lu 2015). In addition to 
the autoinhibitory domain, RAG-2 possesses a CDK phosphorylation site, threonine 
T490. T490, when phosphorylated by CDK2, targets RAG-2 for degradation through the 
Skp2-SCF ubquitination pathway (Li 1996). CDK2 is activated and phosphorylates 
RAG-2 at the G1-S transition, signaling its degradation and thereby restricting expression 
of RAG-2 to the G1 cell phase (Zhang 2011). This is to ensure genomic stability: in 
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G1/G0, the NHEJ repair pathway predominates, so RAG mediated double strand breaks 
are repaired by NHEJ. However, if RAG-2 were allow to persist into S phase, where 
homologous recombination predominates, RAG mediated breaks could be repaired by 
HR, potentially resulting in chromosomal translocations (Papaemmanuil 2014). Indeed, 
RAG-2 proteins bearing a T490A mutation persist into S phase, and mice bearing this 
gene exhibit increased chromosomal abberations and develop leukemias on a P53 -/- 
background (Zhang 2011).  
The PHD finger of RAG-2 is the only domain of the non-core region to have been 
crystallized to date: this domain’s architecture is similar to that of the YNG-2 and ING 
PHD fingers: a zinc finger domain with a pocket for binding the trimethylated 
ammonium of histone H3 lysine 4. Within this pocket, three residues make critical 
contacts with the trimethylammonium, creating a hydrophobic channel that stabilizes the 
interaction between RAG-2 and H3K4me3: Y415, W453, and M443 (Ramon-Maiques 
2007, Shimazaki and Lieber 2014).  Mutation of any of these three residues has been 
shown to be highly detrimental to recombination, rendering the RAG recombinase nearly 
inactive (Lu 2007). In particular, mutation of tryptophan W453 has been known to cause 
SCID syndrome in patients, and exhibits a near complete loss of function in vivo 
(Ramón-Maiques 2007; Matthews 2007; Liu 2007). Evidence suggests that this is due to 
several effects, including the disruption of Pi stacking contacts between the tryptophan 
and the methyllysine, and destabilization of the structure of the PHD finger through the 
elimination of a bulky hydrophobic residue. Paradoxically removal of the entire non-core 
domain of RAG-2 is less detrimental than mutation of W453 in the RAG-2 PHD finger, 
suggesting that the PHD finger of RAG is more than merely a binding site, and may 
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exhibit unique functions (Lu 2007). This phenomenon is the subject of this thesis, and is 












Mechanism of V(D)J recombination and the 12/23 rule 
V(D)J recombination is initiated by the binding of RAG-1 and RAG-2 to a 12-
RSS and a 23-RSS.  Upon binding to the RSSs, the RAG proteins are brought together in 
3-dimensional space to form the pre-synaptic complex, which is a heterotetramer 
comprising a stoichiometry of (RAG-1)2 and (RAG-2)2 bound to both a 12 and 23 RSS 
(Schatz and Swanson 2001). Only complexes containing RSSs with different spacer 
lengths undergo recombination, thereby restricting V(D)J recombination and preventing 
segments of the same gene family from joining (e.g. Jh-Jh joining), which is referred to 
as the 12/23 rule . This restriction is structural in nature: the RAG heterotetramer exhibits 
an asymmetrical “tilt” in the nonamer binding domains of the RAG-1 subunits (Kim 
2015, Ru 2015). This asymmetry disallows concomitant binding of two similar RSSs, i.e. 
two 12 RSSs: the distance on the longer side of the tetramer is simply too far to 
accommodate bind a 12 RSS (Kim 2015). After synapsis, RAG mediated DNA cleavage 
step occurs in two distinct, biochemically separable steps: first, RAG-1 nicks both DNA 
segments on the leading strand at the junction between the RSS and the antigen receptor 
gene segment, generating two 3’-OH groups. Next, RAG promotes a transesterification 
reaction, in which each newly exposed 3’-OH group attacks the complementary DNA 
strand, generating two blunt 5’-phosphorylated signal ends, and two coding ends 
terminating in hairpins. After hairpins are opened by the endonuclease artemis, signal 
ends and coding ends are then joined by the NHEJ pathway to produce signal and coding 





Regulation of the RAG recombinase  
Despite the benefits of V(D)J recombination being able to generate antigen 
receptors that can recognize nearly any epitope, the nuclease activity of the RAG 
recombinase must be carefully regulated. Improper, mistimed, and mistargeted RAG 
activity can lead to DNA double stranded breaks that are potentially oncogenic and 
destabilizing to the genome (Zhang 2011, Papaemmanuil 2014, Mijuskovic 2015). 
Therefore V(D)J recombination is restricted both physically, temporally, and in a lineage 
specific fashion. RAG-1 and RAG-2 gene expression is restricted transcriptionally to 
early lymphocyte development, preventing ongoing recombination through the life of the 
lymphocyte. V(D)J recombination is restricted to the G1 cell cycle phase by the periodic 
destruction of RAG-2 through phosphorylation of T490 at the G1-S transition by CDK2, 
which targets the protein for ubiquitination and degradation by the proteasome (Li 1996, 
Zhang 2011). Restriction of V(D)J recombination to G1 ensures that RAG-mediated 
DNA breaks are repaired by NHEJ, and not by the homologous recombination (HR) 
pathway, which can cause chromosomal translocations if allowed to repair V(D)J 
recombination initiated breaks (Zhang 2011).  
Transcription and epigenetic control of the RAG recombinase  
Within an antigen receptor gene locus, not all V, D, and J gene segments undergo 
V(D)J recombination with equal efficiency. While sequence variation within the 
recombination signal sequences (RSSs) can account for some of this variability, RSS 
usage alone cannot account for the differences observed during lymphoid development. 
More recently it has been appreciated that those segments which lie more proximal to 
transcriptional promoters, such as a DQ52 in the IgH locus, exhibit increased usage in 
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recombination compared to its more distal family members such as DH6 (Schatz and Ji 
2011, Gigi 2014). Ultimately, it was discovered that chromatin modifications associated 
with these transcriptional changes are largely responsible for activation or suppression of 
the V(D)J recombination. A detailed discussion of these mechanisms is outline in the 
following section.  
V(D)J recombination of an antigen receptor gene is invariably preceded by 
transcriptional activation of the locus. This germline transcription, termed “sterile 
transcription” because it produces mRNA that does not code for protein, initiates from 
promoters embedded within antigen receptor loci. Antigen receptor loci undergo dramatic 
alterations in chromatin structure prior to recombination, transitioning from a tightly 
packaged, Dnase resistant state to a Dnase sensitive form (Mills 2003; Yancopoulos 
2012). This change is correlated with active transcription and the production of germline 
transcripts at these genes.  Initiation of germline transcription promotes the establishment 
of euchromatin marks, such as histone acetylation and DNA hypomethylation (Schatz 
and Ji 2011). These observations prompted the accessibility hypothesis, which postulates 
that RAG is actively excluded from antigen receptor loci until a developmental switch 
alters these loci by initiating germline transcription through the gene segments to be 
recombined (Cobb 2006). This active transcription changes the chromatin from an 
inaccessible to accessible form, allowing DNA binding elements including the RAG 
proteins to interact. 
Detailed investigations of the Ig and TCR loci revealed that germline transcription 
stems from multiple promoters located proximal to the V, D, and J gene segment clusters. 
These promoters are activated in a developmental and lineage-dependent fashion prior to 
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recombination: sterile transcription is restricted primarily to immunoglobulin (IgH, Igκ, 
Igλ) loci in developing B cells, and at TCRα, TCRβ, TCRγ, and TCRδ in thymocyte 
precursors (Van Ness 1981; Yancopoulos 1985).  
Transcriptional regulation of recombination in B cells  
The IgH locus can be divided into 3 general regions: the most 5’ region 
containing the Vh gene segments, a central region which contains the Dh and Jh gene 
segements, as well as the principal IgH enhancer Eμ and the intergenic control region 
(IGCR1), and the 3’ region which encodes the various constant region isotypes 
(Subrahmanyam and Sen 2010). Within the immunoglobulin heavy chain (IgH) locus, the 
Vh gene segments are flanked by both sense and anti-sense promoters, which are inactive 
during Dh to Jh joining, but are activated prior to Vh-DJh joining (Bolland 2004, Bolland 
2016). The earliest detectable germline transcription at IgH stems from the D segment 
promoter pDQ52, located between the D and J segments, and from the Eµ enhancer 
(Schlissel 1991). However, pDQ52 is dispensable for V(D)J recombination, although Eµ 
is required for efficient recombination (Afshar 2006).  
Transcription at the IgH locus is governed by several enhancers that interact with 
both the Vh and the Dh and Jh promoters. The primary IgH enhancer, Eμ, lies 3’ of Jh 
gene segments and 5’ of the Cµ exons (Cobb 2006). Deletion of Eμ ablates germline 
transcription over Dh and Jh segments, and blocks V-DJ joining: D-J still occurs, albeit at 
a reduced frequency. These results indicate that additional and/or redundant mechanisms 
might regulate or permit the first step in recombination (D-J joining) even in the absence 
of the enhancer (Afshar 2006, Perlot 2005, Cobb 2006).  One of these redundant elements 
may be cµ, which has exhibited both promoter and enhancer activity (Jung 2006). 
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In addition to promoter and enhancer elements, the IgH locus is subject to control 
by an intergenic control region, IGCR1. IGCR1 insulates Vh segments that lie proximal 
to Dh promoters from crossover transcription. They also function, through an 
unconfirmed mechanism, to normalize Vh usage by discouraging proximal Vh use and 
enhancing distal Vh recombination. It is suspected that CTCF is responsible for this 
activity by binding to IGCR1 and creating chromatin loops that bring distal Vh segments 
into proximity with the Dh region, promoting distal Vh to DJh joining (Guo 2011).  
Transcriptional regulation in developing thymocytes 
Immature thymocytes initiate V(D)J recombination early in their development, 
and target TRCβ for recombination first. Within the TCRβ locus, two promoters and a 
single enhancer govern transcription over the DβJβ clusters. The first promoter, PDβ1 is 
positioned 5’ of the Dβ1 and Jβ1 gene segment families, and the second, PDβ2 lies 3’ of 
the DJβ1 cluster, although its precise location has not been verified (Doty 1999, Sikes 
2011). Additional promoters are interspersed within the Vβ clusters and control local 
transcription of the V β families. The single enhancer (Eβ) is located near the 3’ end of 
the locus, and promotes transcription across both the Dβ1 and Dβ2 clusters (Whitehurst 
2000). Deletion of PDβ1 disrupts V(D)J recombination of Dβ1-Jβ1 segments, but does 
not affect Dβ2-Jβ2 recombination or subsequenct Vβ-DJβ joining (Whitehurst 2000). 
Mice harboring an Eβ deletion are unable to intiate recombination. In contrast, deletion of 
Eβ, which is activated at the earliest thymocyte precursor stage, oblates transcription 
across both clusters locus (McDougall 1988). Concurrent with this loss of transcription, 
heterochromatin is established across TCRβ DβJβ clusters, inhibiting Dβ-Jβ 
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recombination. Together, these results suggest that PDβ1 and PDβ2 independently 
interact with the Eβ enhancer 
Transcription factors involved in V(D)J recombination 
Only a handful of transcription factors have been found to participate in 
transcription of the of antigen receptor genes, and have most have been identified in B 
cells. E2A and EBF, which are alternative splice variants of the same gene, have been 
found to bind to the IgH Eμ enhancer.  Deletion of either E2A or EBF causes a block in 
D-J joining, and inhibits transcription across the DJ clusters (Bain 1999). The paired box 
factor, Pax5, is a B cell specific transcription factor that is expressed early in B cell 
development, and has known binding sites within the IgH locus at the Eμ enhancer. 
Expression of Pax5 promotes proximal Vh-DJh rearrangement, and interestingly, this 
function appears to be independent of germline transcription (Fuxa 2004). Although 
deletion of TFs severely impairs lymphocyte development, deletion of their promoters is 
less detrimental indicating that these factors might play an additional role besides 
promoting germline transcription.  
Large scale changes of chromatin in response to transcription 
Transcriptional activation and repression of these genes is associated with post-
translational modifications of histones: such as acetylation, methylation. Similarly, during 
transcriptional silencing of these loci, the primary modification deposited on the histones 
is methylation. Attempts to uncouple germline transcription from V(D)J recombination 
have not been successful, indicating that transcription and its associated processes are 
essential for recombination. However, transcription of an antigen receptor locus alone is 
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not sufficient to drive recombination. For example, in PAX5 deficient cells, some Vh 
segments are still transcribed, but never undergo recombination (Fuxa 2005). From these 
data it appears that the role of transcription is more than just generating accessible 
antigen receptor loci by altering the local chromatin, but rather has profound effects on 
DNA looping and the topology of antigen receptor loci (Chaumeil 2013). Indeed, recent 
findings suggest that the transcription factors recruited during germline transcription are 
of equal or greater importance to successful recombination than transcription alone. 
Chromosomal looping effected by factors such as CTCF and PAX5, which bind the 
IGCR and Eμ respectively have been proposed to restrict V(D)J recombination to 
particular segments by trapping RAG within a CTCF-generated chromatin loop (Bolland 
2016, Lin 2015, Feehley 2012). Deletion of the IGCR in the IGH locus results in 
increased proximal V-DJ joining, and a general increase in the amount of overall 
recombination in IGCR deficient cells, which could be explained by the inclusion of 
proximal Vh segments within a chromosomal loop with the Dh and Jh segments when 
IGCR is deleted (Hu 2015, Guo 2011).  
In addition to alterations in chromatin looping and structure, transcription may 
also alter DNA nucleosome interactions directly. Bevington et al. report that active 
transcription within the Vκ locus may transiently displace the H2A/H2B heterodimer 
from nucleosomes, resulting in altered nucleosome DNA contacts that allow RAG to bind 
and cleave at RSSs (Bevington 2013). Nucleosome remodeling factors such as SWI/SNF 
have also been proposed to regulate germline transcription and locus accessibility at IgH 
through interactions with Eµ (Osipovich 2009). SWI/SNF has also been proposed to alter 
interactions of RSSs with nucleosomes, sliding the nucleosomes so that RSSs are 
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repositioned in a manner that allows RAG to interact directly with the RSS as free 
unbound DNA (Baumann 2003, Kassabov 2003, Shimazaki 2014). It is difficult to parse 
out when these various mechanisms are active during B-cell development, and whether 
they work in concert with one another, work as redundant mechanisms for accessibility, 
or are simply a non-specific byproduct of general transcription. Regardless, the 
transcription factors recruited during germline transcription appear to be the main 
effectors in driving V(D)J recombination, rather than the general accessibility of DNA 
generated by transcription. 
Epigenetic modification in V(D)J recombination 
Mammalian genomes are organized within the nucleus into chromatin: a DNA-
protein hybrid in which winds DNA around nucleosomes, thereby packing the DNA into 
a much more compact form than naked, free DNA. Nucleosomes are composed of 4 
histone proteins, H1, H2A/H2B, H3, H4. There are multiple isoforms of the proteins, but 
a discussion of their roles is beyond the scope of this thesis. A nucleosome is composed 
of two copies of H2A, H2B, H3, and H4: DNA is wound around this protein complex 
like thread on a spool. Each nucleosome winds ~146 base pairs of DNA. Nucleosomes 
are naturally “phased” across the genome, meaning they show a periodic distribution of 
~150 base pairs (Strahl 2000). This phasing can be altered by a number of chromatin 
remodeling complexes including the SWI/SNF ATP dependent nucleosome remodeling 
complex. It has been suggested that nucleosome phasing over RSSs and antigen receptor 
gene segments may control RAG activity by permitting or rejecting RAG binding to the 
RSS, Several groups have shown that the remodeling of nucleosomes by SWI/SNF to 
expose the RSS as naked DNA permits RAG binding and recombination of antigen 
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receptor gene segments, but these data are somewhat unclear, as SWI/SNF remodeling 
also leads to hyperacetylation of the histones, which was shown to independently 
stimulate recombination (Shimazaki 2014, Roth 2000). Positioning of antigen receptor 
loci within the nucleus also appears to affect susceptibility to undergo rearrangement by 
V(D)J recombination. In maturing B cells, the IgH and Igκ loci migrate from the nuclear 
periphery to a more centralized position within the nucleus (Kosak 2002). The IgH locus 
migrates before Igκ; this migration coincides with the initiation of Dh-Jh recombination. 
Upon productive rearrangement of one allele, recombination of the incompletely 
rearranged second allele is suppressed by migration of the allele back to the nuclear 
periphery, and rearrangement of the light chain (Igκ) is initiated (Kosak 2002, Fuxa 
2004).   
In addition to large scale chromatin architecture, it appears that the 
transcriptionally associated histone post-translational modifications are critical in the 
regulation of V(D)J recombination, particularly modifications of histones H3 and H4. 
These modifications, and their associated transcriptional status are detailed below.  
Histone H3 Lysine 9 methylation 
 In transcriptionally silent chromatin, e.g. DNA which is inaccessible to RNA or 
DNA polymerases or transcription factors, histone H3 is dimethylated at lysine 9 
(H3K9me2). In B and T cells, deposition of H3K9me2 is carried about the G9a 
methyltransferase. In developing B-cells, H3K9me2 is initially deposited on IgH V 
segments (Johnson 2004). Removal of H3K9me2 in B-cells occurs in a PAX5 dependent 
manner, at the pro-B to pre-B transition, immediately prior to Vh-DJh joining (Johnson 
2004). Deposition of H3K9me2 is sufficient to inhibit V(D)J recombination: in an elegant 
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experiment, Osipovich et al demonstrated that targeting of a G9a methyltransferase to a 
TCRβ minilocus, and subsequent H3K9me3 deposition, was sufficient to inhibit both 
transcription and V(D)J recombination of the minilocus (Osipovich 2004).  
DNA methylation 
DNA methylation is a modification of cytosine which occurs at CG dinucleotides, 
referred to as CpG islands (Suzuki and Bird 2008). In uncommitted lymphoid progenitors 
and non-lymphoid cells, antigen receptor loci exhibit extensive CpG methylation (Mather 
1983, Storb 1983). As cells commit to the B-lineage, there is concurrent demethylation of 
Igκ and IgH (Mostoslavsky 1998, Selimyan 2013). A detailed analysis of B-cells at 
various stages of V(D)J recombination at the IgH locus demonstrated that the Dh and Jh 
gene segment families remain methylated prior to Dh-Jh  recombination, but are found to 
be partially demethylated upon Dh-Jh joining (Selimyan 2013). Unsurprisingly the Eµ 
enhancer was found to be demethylated at all stages in these cells, likely a result of its 
strong enhancer function. Further, demethylation at the Dh and Jh appears to be 
dependent on interactions with Eµ. Mice bearing an H19 imprinting control region (ICR) 
inserted between Eµ and the distal Jh segments exhibited hypermethylation across both 
the Dh Jh clusters, and a marked decrease in germline transcription and Dh-Jh 
recombination (Puget 2016). Even in cells which undergo Dh-Jh joining, the DhJH 
recombination products remained methylated. Taken together these data suggest that the 
presence of DNA methylation discourages V(D)J recombination, and that temporal 
control of V(D)J recombination may be regulated in part by Eµ dependent demethylation 




Histone H3 and H4 acetylation  
Acetylation of histones H3 and H4 is a hallmark of actively transcribed 
chromatin. Deposition of acetylation is thought to occur concurrently with transcription, 
and is found across the entire transcribed locus. Histone acetylation is correlated with 
antigen receptor genes poised to undergo rearrangement (McMurry & Krangel 2000, 
Shetty & Shatz 2015). A particular acetylation mark, H3K27Ac, is suspected of direct 
interactions with the RAG recombinase, potentially through interactions with the RAG-1 
RING domain (Maman 2016). However the functional role of this acetylation mark is 
unclear, particularly since histone acetylation is ubiquitous across transcribed genes, but 
binding of RAG-1 is specific to antigen receptors (Ji 2010).  
Histone H3 Lysine 4 methylation  
Like acetylation, H3K4me3 is a histone post-translational modification that is 
deposited in a transcription dependent manner. However, unlike histone acetylation, 
which shows broad distribution across actively transcribed genes, H3K4me3 is deposited 
in localized sites within the genome, such as the promoters and enhancers of genes 
(Subrahmanyam and Sen 2010). The presence of H3K4me3 is positively correlated with 
active V(D)J recombination, suggesting a link between recombination and this histone 
mark (Yancopoulos 1985). Insights into the regulation of V(D)J recombination at the 
epigenetic level came with the discovery that one of RAG subunits, RAG-2, contains a 
plant homeodomain (PHD) that specifically interacts with histone H3 when it is tri-
methylated at lysine 4 (H3K4me3) (Liu 2007; Matthews 2007; Ramón-Maiques 2007). 
This provided the first mechanistic link between this “active chromatin” post-
translational modification and V(D)J recombination. Initial experiments suggested that 
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the interaction between H3K4me3 and RAG-2 functioned in localization of the RAG 
complex (Matthews 2007). However, two lines of reasoning argue against this 
interpretation: first, RAG-1 is able to localize to the correct genomic location 
independent of RAG-2, and second, deletion of the entire RAG-2 non-core domain does 
not ablate V(D)J recombination, while a single point mutation within the RAG-2 PHD 
finger nearly eliminates recombination (Liu 2007). Unlike other PHD fingers, the RAG-2 
PHD binding site for H3K4me3 contains a channel that is not filled by H3K4me3 alone. 
An H3K4me3 peptide containing an additional modification, symmetrical methylation of 
arginine 2 of histone H3, has shown to enhance RAG-2 binding to H3K4me3 by 
occupying this channel. H3R2me2K4Me3 exhibits enhanced affinity for the RAG-2 PHD 
of nearly 4 fold, suggesting that the presence of both marks might “tune” RAG-2 binding 
and activity in vivo, although ChIP experiments have shown that RAG-2 binds 
ubiquitously over any H3K4me3 bearing genomic region (Ji 2010, Shetty & Schatz 
2015).  
Regulation of RAG activity by H3K4me3 
Careful enzymatic analysis revealed that binding of H3K4me3 to RAG-2 is more 
than just a localization signal. DNA cleavage assays utilizing a 12 and 23 RSS DNA 
substrate and highly purified RAG proteins demonstrated that the addition of an 
H3K4me3 peptide in trans actively stimulated DNA cleavage by the RAG complex (Lu 
2015, Shimazaki 2012, Grundy 2010). Similarly, an H3K4me3 peptide added in trans 
increased the affinity of RAG for DNA substrates, and stabilized the RAG complex when 
bound to DNA (Liu 2007, Shimazaki 2009). Mutation of a critical tryptophan within the 
RAG-2 PHD finger, W453, abolishes binding of H3K4me3 to RAG-2 and also renders 
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RAG unstimulable by H3K4me3. These observations led us to the hypothesis that 
H3K4me3 is an allosteric regulator of the RAG recombinase. Evidence supporting this 






















During lymphocyte development, the genes encoding antigen receptors are 
assembled from discrete gene segments by V(D)J recombination.  This process is 
initiated by the proteins RAG-1 and RAG-2, which together bind and cleave DNA at 
recombination signal sequences (RSSs) that flank the participating gene segments 
(Gellert 2002; Schatz and Swanson, 2011).  There are two classes of RSS, termed 12-
RSS and 23-RSS, in which the heptamer and nonamer elements are separated by spacers 
of 12 bp or 23 bp, respectively.  DNA cleavage by RAG involves nicking at the junction 
between the RSS and the coding sequence, followed by transesterification to produce a 
blunt, 5’-phosphorylated signal end and a coding end that terminates in a hairpin.  Under 
physiologic conditions complete cleavage requires the pairing of a 12-RSS with a 23-
RSS, so that recombination between like segments is suppressed (Schatz and Swanson, 
2011).   
 V(D)J recombination acts in an ordered, locus-specific fashion during lymphoid 
development.  In the B lineage, for example, the immunoglobulin heavy chain (IgH) 
locus is rearranged before the light chain loci and assembly of an Ig heavy chain gene 
proceeds by sequential D-to-Jh and Vh-to-DJh joining (Alt 1985).  Upon productive 
rearrangement, further recombination at the IgH locus is suppressed, thereby enforcing 
monoallelic expression of Ig heavy chain (Jung 2006).  The ability of gene segments to 
undergo V(D)J recombination is positively correlated with transcription at the 
unrearranged locus and with histone modifications characteristic of active chromatin, 
including hypermethylation of histone H3 at lysine 4 (Chakraborty 2007; Liu 2007; 
Matthews 2007; Subrahmanyam 2012).  
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 RAG-1 and RAG-2 are 1040 and 527 amino acid residues long, respectively. 
Although the canonical non-core region of RAG-2, comprising residues 387 through 527, 
is dispensable for DNA cleavage in vitro, removal of this region has debilitating effects 
in vivo, including decreased recombination frequency (Steen 1999) and an increase in 
aberrant recombination (Sekiguchi 2001; Talukder 2004).  Interpretation of these effects 
is complicated by the presence of domains within the RAG-2 non-core region that 
support destruction of RAG-2 at the G1-S transition (Jiang 2005; Lee and Desiderio 
1999; Zhang 2011), govern nuclear import of RAG-2 in cycling cells (Ross 2003) and 
mediate binding of RAG-2 to H3K4me3 (Liu 2007; Matthews, 2007; Ramon-Maiques  
2007).  This last interval, which spans residues 415 through 487, comprises a non-
canonical plant homeodomain (PHD) finger (Callebaut and Mornon 1998; Ramon-
Maiques 2007).  In the context of full-length RAG-2, engagement of H3K4me3 by the 
PHD finger promotes recombination in vivo (Liu 2007; Matthews 2007).  Indeed, 
soluble, synthetic peptides bearing the H3K4me3 modification stimulate cleavage of RSS 
substrates by RAG in vitro (Grundy 2010; Shimazaki 2009), consistent with the 
interpretation that H3K4me3 is an allosteric activator of the V(D)J recombinase. 
Paradoxically, complete removal of the RAG-2 non-core region impairs V(D)J 
recombination less severely than does selective mutation of the PHD finger (Cuomo and 
Oettinger 1994; Sadofsky 1994).  Moreover, core RAG-2 supports D-to-JH joining in 
vivo (Akamatsu 2003; Kirch 1998; Liang 2002), while the full-length RAG-2(W453A) 
mutant, which is unable to bind H3K4me3, does so only weakly (Liu et al., 2007).  These 
observations suggest that H3K4me3 imposes allosteric control on V(D)J recombination. 
By identifying second site mutations that rescue the activity of RAG-2 bearing a 
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debilitating mutation in the PHD finger we now uncover an autoregulatory region within 
RAG-2 that imposes allosteric control on V(D)J recombination.  We demonstrate that 
disruption of autoinhibition is associated with constitutive increases in the affinity of 
RAG for substrate DNA and in the rate of DNA cleavage, thereby mimicking the 
engagement of H3K4me3.  Our observations provide strong support for a model in which 
epigenetic control of RAG is enforced by an autoinhibitory domain whose action is 




Robust stimulation of RAG activity by exogenous H3K4me3 upon removal of 
endogenous H3K4me3 (In collaboration with Dr. Chao Lu) 
To study the mechanism of interaction between the PHD finger and H3k4me3, we 
first established a robust system for studying allosteric activation of RAG by H3K4me3.  
Although exogenous H3K4me3 has been shown to stimulate DNA cleavage by RAG, 
standard RAG preparations nonetheless support RSS cleavage in the absence of 
exogenous H3K4me3, and the responsiveness of these preparations to exogenous 
H3K4me3 is inconsistent.  These observations suggested the presence of varying amounts 
of copurifying, endogenous H3K4me3.  Indeed, we discovered that standard amylose 
affinity preparations of MBP-tagged RAG fusion proteins (Fig 2.1 A) were contaminated 
with histone H3K4me3.  When we employed a protocol that included sonication before 
amylose affinity chromatography, contaminating H3K4me3 was removed.  All RAG 




Figure 2.1. A. Separation of RAG from endogenous H3K4me3. Detection of RAG proteins 
(upper panel) or H3K4me3 (lower panel) by immunoblotting with anti-myc or anti-H3K4me3 
antibody, respectively. The RAG fusion proteins cRAG-1-MH (cRAG-1) and fRAG-2-MH 
(fRAG-2) (lanes 1 – 3, lane 7 and lane 8) or cRAG-1ct-MH (cRAG-1ct) and fRAG-2-MH (lanes 
4 – 6). B. Stimulation of H3K4me3-depleted RAG by exogenous H3K4me3. Coupled cleavage 
reactions contained radiolabeled 12-RSS and unlabeled 23-RSS. Additions of RAG and 
H3K4me0 or H3K4me3 are indicated above. Positions of hairpin (HP) and nicked (N) products 
are indicated by arrows. M, 10 bp marker ladder. C. Accumulation of hairpin product (top) or 
nicked intermediates (bottom) at 1 hr is plotted in nM as a function of H3K4me0 (gray 





 We proceeded to assess the effect of exogenous H3K4me3 on DNA cleavage by 
RAG in the absence of endogenous H3K4me3.  In these assays we employed a version of 
RAG-1 lacking the amino-terminal non-core region but retaining the carboxy-terminal 
non-core region (cR1ct-MH, Fig 1 C) because RAG complexes containing cR1ct-MH are 
more robustly stimulated by H3K4me3 than complexes containing canonical core RAG-1 
(Grundy 2010), and because we obtained complexes containing cR1ct-MH in at least 20-
fold greater yield than complexes containing full-length RAG-1.  Full-length RAG-2 
(fR2-MH, Fig 1D) and cR1ct-MH fusion proteins were coexpressed and copurified (Fig 
2.1 A); the resulting preparation was free of detectable endogenous H3K4me3 (Fig 2.1 A, 
lanes 4 - 6). This RAG complex was assayed in vitro for coupled cleavage of a 
radiolabeled 12-RSS in the presence of unlabeled 23-RSS substrate and increasing 
amounts of a histone H3-derived peptide containing trimethylated lysine 4 (H3K4me3) or 
unmethylated lysine 4 (H3K4me0).  Accumulation of hairpin products was robustly 
stimulated in a dose-dependent fashion by H3K4me3, but not by H3K4me0 (Fig 2.1 C).  
Under these conditions the yield of hairpin end-products showed about 4.5-fold maximal 
stimulation with half-maximal stimulation occurring at 0.6 - 1.25 µM H3K4me3.  These 
results demonstrated the ability of soluble H3K4me3 to stimulate the cleavage of 12-RSS 
substrates by RAG and suggested that the removal of endogenous H3K4me3 would 
provide a more well-defined RAG preparation with which to evaluate the effects of 






Stimulatory effect of H3K4me3 on substrate binding  
Our coupled cleavage experiments indicated that H3K4me3 was altering RAG 
activity by increasing affinity for substrate, increasing the catalytic activity of the 
enzyme, or both.  To distinguish between these possibilities, we independently assessed 
substrate binding and catalysis with co-purified RAG-1 and RAG-2.  To measure affinity 
for DNA substrate, a canonical 12-RSS fragment was incubated with wild-type RAG at 
concentrations ranging from 0 to 300 nM in the presence of 4µM H3K4me0 or H3K4me3 
peptide.  Incubation was carried out in the presence of 5mM Ca++, which supports the 
binding of RAG to substrate in the absence of DNA cleavage.   The fraction of total 
substrate remaining in the unbound state was determined by gel electrophoresis (Fig. 2.2 
A) and expressed as a function of active RAG concentration (Fig 2.2 B), as defined by 
burst kinetics under the assumption that the active unit is a heterotetramer of composition 
(RAG-1)2(RAG-2)2 (Yu and Lieber 2000).  Dissociation constants, KD, were determined 
as described in Experimental Procedures.  The addition of H3K4me3 was accompanied 




In the presence of H3K4me3 wild-type RAG bound substrate with an an estimated KD of 
76 nM, while in the presence of H3K4me0 the KD was 242nM.  
H3K4me3 stimulates catalysis of DNA cleavage 
The foregoing experiments suggested that H3K4me3 might have discrete 
stimulatory effects on substrate binding and catalysis. We therefore subjected RAG-2 in 
complex with cRAG-1-ct to burst kinetic analysis. Reactions were carried out at an active 
RAG tetramer concentration of 1.5 nM in the presence of 4 µM H3K4me0 or H3K4me3 
peptide (Fig 2.3 A).  Following determination of Vmax (Fig 2.3 A, B), kcat was estimated 
(Experimental Procedures).  We observed turnover rates of 0.83 min-1 and 3.76 min-1 for 
wild-type RAG-2 in the presence of H3K4me0 or H3K4me3, respectively (Fig 2.3 B,C), 
consistent with previous estimates (Shimazaki 2009).   
Figure 2.2 Stimulatory effects of H3K4me3 on RAG binding. A. Electrophoretic mobility shift 
assay (EMSA) for binding of wild-type RAG to a consensus 12-RSS in the presence of 
H3K4me0 or H3K4me3 peptide as indicated at top. Probe, 12 RSS incubated in the absence of 
RAG. The concentration, in mM, of active RAG in each binding reaction is indicated above the 
lane. B. H3K4me3 reduces the KD of RAG-RSS binding. The fraction of free probe (fraction 
DNA unbound) in each binding reaction of (A) was plotted as a function of active RAG 
concentration. Data from reactions containing H3K4me0 and H3K4me3 are indicated by blue 




Taken together these results are consistent with a model in which the RAG activity is 
suppressed, limiting both substrate binding and catalysis which are overcome upon 
binding of H3K4me3.   
 
 
Figure 2.3. Stimulation of RAG DNA nicking by H3k4me3. A. Assay for RSS nicking.  
Reactions contained 1.5 nM fRAG-2-MH and 12-RSS substrate HL44/45 at 10, 20, 40 or 60 
nM.  Reactions were supplemented with 4 µM H3K4me0 or H3K4me3 peptide as indicated at 
top.  Accumulation of nicked product (arrow) was assayed at times ranging from 0.5 min to 3 
min.  B. Concentration of nicked product as determined in (D) is plotted as a function of time 
for each substrate concentration.  Blue, 10 nM; orange, 20 nM; gray, 40 nM; and yellow, 60 
nM.  Left, reactions containing H3K4me0; right, reactions containing H3K4me3.  Vmax was 
determined from the slopes of the individual kinetic curves by non-linear regression analysis as 
described in Experimental Procedures; kcat = Vmax/[RAG]T, where [RAG]T is the total 







The accessibility of antigen receptor loci to V(D)J recombination is tightly 
associated with transcriptional activity and with epigenetic modifications characteristic of 
active chromatin.  Binding of the RAG-2 PHD finger to one such mark, H3K4me3, is 
essential for efficient V(D)J recombination in vivo.  This has suggested that 
recombination requires the simultaneous engagement by RAG of appropriately paired 
RSSs and one or more H3K4me3 moieties.  The ability of untethered H3K4me3 to 
stimulate cleavage of naked DNA by RAG, however, is consistent with the interpretation 
that H3K4me3 does not simply function as a docking site for the recombinase but rather 
as an allosteric activator that relieves autoinhibition exerted by some feature of the RAG 
complex.   
 Our ability to measure the stimulation of RAG activity by exogenous H3K4me3 
relied upon a purification scheme that separated RAG from contaminating, endogenous 
H3K4me3.  The ability of exogenous H3K4me3 to stimulate the coupled cleavage 
activity of wild-type RAG was dependent, as expected, on binding of H3K4me3 to the 
PHD finger of RAG-2.  H3K4me3 binding exerts at least two effects that contribute to 
enhanced RSS cleavage activity in vitro: increased affinity of RAG for substrate and a 
faster catalytic rate.  Our results are consistent with a model in which RAG is maintained 
in a state of low affinity for the RSSs until nearby transcriptional activation promotes 
allosteric activation through the deposition of H3K4me3. In this view, engagement of the 
PHD finger by H3K4me3 would relieve inhibition indirectly, perhaps through 






pcDNA3.1 Plasmids encoding full length RAG-2, and plasmids encoding 
maltose-binding protein (MBP) fusions to full-length RAG-1, core RAG-1 or full-length 
RAG-2, tagged at the c-termini with a myc epitope and polyhistidine were generated by 
Alyssa Ward and Chao Lu. To construct a plasmid expressing core RAG-1ct (Grundy 
2010), codons 384 through 1040 of mouse RAG-1 were amplified by PCR and ligated in 
frame between cassettes encoding MBP and myc-polyhistidine that had been inserted into 
the vector pcDNA3.1. 
Burst kinetic analysis 
RAG protein was combined at varying nominal concentrations with 200 nM total 
radiolabeled HL44/45 in binding buffer containing 1% glycerol (reaction volume 10 l) 
and incubated for 20 min at 37°C, at which time MgCl2 was added to 5 mM.  Incubation 
was continued for an additional 30 min at 37°C.  Reactions were stopped by addition of 
10 l 90% formamide-TBE and heated for 5 min at 95°C.  Products were fractioned by 
electrophoresis on a 15% polyacrylamide-urea gel, visualized by a phosphorimager 
quantified using ImageQuantNL.  The active fraction of each RAG preparation was 
determined by (1) plotting accumlation of nicked product ([N]) as a function of time for 
each concentration of total RAG; (2) extrapolating rates to zero time, thereby obtaining 
the initial burst of nicked product formation ([N]0) at each nominal RAG concentration; 
and (3) expressing [N]0 as a linear function of nominal RAG concentration:  
[𝑁]0 = 𝑓𝑎 ∙ [𝑅𝐴𝐺]𝑇 + 𝑏 
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where [RAG]T is the total (nominal) concentration of RAG, assuming a tetrameric 
stoichiometry of (RAG-1)2(RAG-2)2, and fa is the fraction of  [RAG]T that is active (Yu 
and Lieber, 2000). 
Assays for coupled cleavage 
RAG (1 nM active tetramer, as determined by burst kinetic analysis) was 
combined in binding buffer with 5 nM HL44/45, 5nM HL46/47 and varying 
concentrations of a peptide corresponding to the amino-terminal 21 residues of histone 
H3, either trimethylated at lysine 4 (H3K4me3; Anaspec, 64194) or unmethylated 
(H3K4me0; Anaspec, 61701), in a reaction volume of 10 µl.  After incubation for 20 min 
at 37°C, MgCl2 was added to 5 mM and incubation was continued for an additional 1 hr.  
Reactions were stopped and products were analyzed as above. 
Assays for DNA nicking by full-length RAG proteins 
Full length RAG (1 nM active tetramer, as determined by burst kinetic analysis) 
was combined in binding buffer with 5 nM HL44/45 and varying concentrations of a 
peptide corresponding to the amino-terminal 21 residues of histone H3, either 
trimethylated at lysine 4 (H3K4me3; Anaspec, 64194) or unmethylated (H3K4me0; 
Anaspec, 61701), in a reaction volume of 10 µl.  After incubation for 20 min at 37°C, 
MgCl2 was added to 5 mM and incubation was continued for an additional 30 min.  










 All forms of DNA processing – replication, transcription, recombination and repair 
– employ allosteric regulation, often as a basis for molecular discrimination but also to 
establish a sequence of interactions or to bias the outcome of a reaction.  In many 
instances the allosteric ligand is a specific DNA structure, as in Cre-mediated 
recombination, in which the Holliday junction intermediate effects allosteric 
conformational changes that switch active and inactive Cre monomers (Guo 1997).  In 
other instances the allosteric ligand is a DNA-bound protein array, as in  integration, 
which is driven to completion by a flanking DNA-protein array that biases the 
conformation of λ-integrase (Biswas 2005).  
 V(D)J recombination, the process by which antigen receptor genes are assembled, 
is also subject to allosteric control, but in this case the allosteric ligand is a specific 
chromatin mark rather than a DNA structure.  V(D)J recombination is initiated by RAG-1 
and RAG-2, which together cleave DNA at recombination signal sequences (RSSs) 
flanking the participating gene segments (Schatz and Swanson 2011). There are two 
classes of RSS, termed 12-RSS and 23-RSS, in which heptamer and nonamer elements 
are separated by spacers of 12 bp or 23 bp; physiological DNA cleavage requires the 
pairing of a 12-RSS with a 23-RSS (Schatz and Swanson 2011)).  V(D)J recombination 
acts in an ordered, locus-specific fashion during lymphoid development.  The 
accessibility of gene segments to V(D)J recombination is positively correlated with 
transcription at the unrearranged locus and with histone modifications characteristic of 
active chromatin, including hypermethylation of histone H3 at lysine 4 (Chakraborty 
2007, Jung 2006, Liu 2007, Matthews 2007, Morshead 2003, Subrahmanyam 2012). 
37 
 
 RAG-1 and RAG-2 are 1040 and 527 amino acid residues long, respectively.  The 
catalytic core and DNA-binding functions are largely contained within RAG-1 (Kim 
2015).  RAG-2, which is also essential for DNA cleavage activity, comprises part of a 
putative DNA-binding cleft and participates in formation of the active site (Kim 2015).  
Although residues 387 through 527 of RAG-2 are dispensable for DNA cleavage in vitro, 
this region supports several regulatory functions in vivo, including binding of RAG-2 to 
H3K4me3  (Liu 2007, Matthews 2007, Ramon-Maiques 2007). This function is mediated by 
a non-canonical plant homeodomain (PHD) finger that spans residues 415 through 487 
(12, 13).  Engagement of H3K4me3 by the PHD finger promotes recombination in vivo 
(Ramon-Maiques 2007, Matthews 2007) and synthetic peptides bearing the H3K4me3 
modification stimulate cleavage of RSS substrates by RAG in vitro (Grundy 2010, Lu 
2015, Shimazaki 2009), consistent with the interpretation that H3K4me3 is an allosteric 
activator of the V(D)J recombinase.   
 This interpretation was reinforced by the identification within RAG-2 of an 
autoregulatory region, the presence of which was revealed by second site mutations that 
rescue the activity of RAG-2 lacking a functional PHD finger (Lu 2015).  Disruption of 
this autoregulatory region is associated with constitutive increases in RSS binding 
affinity, catalytic rate and recombination frequency, thus mimicking the stimulatory 
effects of H3K4me3 (Lu 2015).  These observations support a model in which RAG 
activity is suppressed by an autoinhibitory domain whose action is relieved by active 
chromatin.   
 Allosteric activation is usually accompanied by a change in the distribution of 
accessible protein conformations in the ligand-bound state (Mortlagh 2014).  We asked 
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whether the conformational distribution of RAG is altered upon binding of H3K4me3 to 
the RAG-2 PHD finger.  To quantify effects of H3K4me3 on the conformations of RAG-
1 and RAG-2 we carried out differential isotopic chemical footprinting of solvent-
exposed cysteine thiols, in combination with mass spectrometry (Chen 2012).  Strikingly, 
binding of H3K4me3 to RAG-2 is accompanied by robust increases in the solvent 
accessibility of RAG-1 within the nonamer-binding domain, in a second putative RSS-
binding domain and in the ZnH2 domain, which acts as a scaffold for the catalytic center 
(Kim 2015).  These H3K4me3-induced changes in solvent accessibility are abolished by 
mutation of the RAG-2 PHD finger.  Our observations provide direct evidence that 
engagement of H3K4me3 by the RAG-2 PHD finger is associated with discrete changes 
in the conformational distribution of RAG-1, consistent with the stimulatory effects of 




Results and Discussion 
 Information indicating engagement of H3K4me3 by the RAG-2 PHD finger must 
be communicated within the RAG tetramer in such a way that substrate affinity and 
catalytic rate are increased.  An allosteric ligand can be thought to act on an ensemble of 
protein native states by inducing a shift in the energetic distribution of those states and 
their associated protein conformations (Mortlagh 2014).  In accordance with this view, 
binding of H3K4me3 to the RAG-2 PHD finger may be accompanied by a shift in the 
distribution of RAG native states, so as to favor conformations associated with increased 
DNA binding and catalysis.  We sought to obtain physical evidence for the induction of 
such conformational changes by H3K4me3. 
 Conformational states are expected to differ with respect to the detailed 
accessibility of amino acid side chains to solvent (Marsh 2011).  Solvent-accessible 
cysteine side chains are susceptible to alkylation by monobromobimane (mBBr), which 
reacts with free thiols to produce a covalent mBBr-thiol adduct (Chen 2012).  We used 
this reaction, in combination with mass spectrometry, to determine the effect of 
H3K4me3 binding on the distribution of solvent-exposed cysteine thiols in the RAG 
tetramer.   
 The version of RAG-1 employed here, cR1ct, lacks the amino-terminal non-core 
region and is more soluble than the wild-type protein but retains responsiveness to 
H3K4me3 in complexes with RAG-2 (Grundy 2010, Lu 2015).  In addition to full-length, 
wild-type RAG-2, we employed RAG-2(W453A), in which the PHD finger cannot bind 
H3K4me3 (Liu 2007).  These RAG-2 variants, tagged at the amino terminus with MBP, 
were coexpressed individually with MBP-tagged cR1ct and RAG tetramers were purified 
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by a protocol that removes endogenous H3K4me3 (15) (Fig 3.1A). The active fractions 
of these RAG preparations, as determined by burst kinetics (Fig 3.1B – C) ranged from 




















































































Figure 3.1 A. Purification of wild-type and mutant RAG proteins. (A) Complexes of cRAG-1-
ct with ful-length wild-type RAG-2 (WT) or RAG-2(W453A) were purified by sonication and 
amylose afinity chromatography. Aliquots of each fraction were separated by SDS/PAGE 
alongside a dilution series of BSA.W denotes wash; E1, E2, and E3 denote sequential amylose 
eluates. Al samples were run on the same gel. B. Burst kinetic analysis of wild-type RAG. A 
complex of cRAG-1ct with ful-length, wild-type RAG-2 was assayed for nicking of a 12-RSS 
substrate at various nominal RAG concentrations. Accumulation of nicked product is ploted as 
a function of time at each nominal RAG concentration as indicated in the inset. C. Assay of 12-
RSS nicking by ful-length RAG-2(W453A) in complex with cRAG- 1-ct, performed at various 
nominal RAG concentrations and displayed as in B. D. Estimation of the active fraction. Slope 





Equivalent amounts of each active RAG tetramer were assayed in vitro for couple 
cleavage of a radiolabeled 12-RSS in the presence of unlabeled 23-RSS substrate and 
increasing amounts of a histone H3-derived peptide containing trimethylated lysine 4  
(H3K4me3) or unmethylated lysine 4 (H3K4me0).  
 
Figure 3.2 H3K4me3 stimulates coupled DNA cleavage by RAG complexes containing wild-
type RAG-2 but not RAG-2(W453A). A. Coupled cleavage reactions contained radiolabeled 
12-RSS and unlabeled 23-RSS. Reactions contained wild-type (WT) RAG-2 or RAG-
2(W453A) as defined at top. K4me0 and K4me3, reactions supplemented with 0.5, 1, 2 or 4 
μM H3K4me0 or H3K4me3 peptide; 0, reactions lacking peptide. Markers corresponding to 
intact substrate (S) hairpin product (H), or nicked product (N) are indicated at right. All samples 
were run on the same gel. B. Accumulation of hairpin product at 1 h (nanomolar product) is 
plotted as a function of the concentration of H3K4me0 or H3K4me3. Blue  quares, wild-type 
RAG-2 with H3K4me3; orange squares, wild-type RAG-2 with H3K4me0; gray circles, RAG-
2(W453A) with H3K4me3; and black circles, RAG-2(W453A) with H3K4me0. 
A 
B 
WT RAG2 W453A RAG2 
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 As previously reported (Lu 2015), the activity of wild-type RAG was stimulated in 
a dose-dependent fashion by H3K4me3, but not by H3K4me0, while the RAG-
2(W453A) mutation abolished responsiveness to H3K4me3 (Fig. 3.2A, B).  We 
proceeded to employ these preparations in chemical footprinting and partial proteolysis 
assays.  
Mapping solvent accessibility of RAG cysteine thiols by differential isotopic 
chemical footprinting 
The chemical footprinting procedure is outlined in Fig 3.3 A.  Two protein 
conformations are depicted, one in the absence (Fig 3.3 A, top left) and one in the 
presence (Fig 3.3 A, top right) of bound H3K4me3; these single conformations are meant 
to represent populations of conformations whose distributions differ.  RAG preparations 
were pre-incubated in the presence of H3K4me3 or H3K4me0 and then subjected to a 1 
minute pulse of alkylation with light mBBr ([1H]mBBr).  After alkylation by [1H]mBBr 
was quenched, RAG was denatured in guanidinium chloride (GdmCl) and unmodified 
cysteine thiols were alkylated with hexadeuterated mBBr-d6 ([2H]mBBr).  Light 
alkylation is represented in Fig. 3.3 A by red plain R; heavy alkylation by red boldface R.  
The modified RAG subunits were digested with trypsin and the products were analyzed 
by liquid chromatography tandem mass spectrometry (LC-MS/MS).  Idealized mass 
spectrograms are diagrammed at the bottom of Fig 3.3 A, where the x axes denote m/z, 
the y axes denote chromatographic retention time and the z axes denote relative peak 
intensity.  The mass spectra on the left depict the theoretical distribution of 13C 








Figure 3.3.  Mapping H3K4me3-induced conformational changes in RAG by pulse alkylation 
mass spectrometry.  A. Experimental scheme.  Binding of H3K4me3 is proposed to result in a 
shift in the distribution of RAG conformations, accompanied by a change in the accessibility of 
some cysteine thiols to solvent.  Solvent accessibility is probed by pulse alkylation with 
[1H]mBBr. Following quenching of the first alkylation reaction and denaturation of RAG in 
guanidinium chloride (GdmCl), remaining unmodified cysteine thiols are alkylated with 
[2H]mBBr.  RAG is then fragmented with trypsin and peptides resolved by liquid 
chromatography-mass spectrometry (LC-MS).  For each cysteine-containing peptide, total light 
or heavy alkylation (ΣCP,L and  ΣCP,H, respectively) is determined by summing the 
corresponding peak areas over two dimensions (red arrows): isotopologues and retention time 
(rt). B – E. Representative spectra of four mBBr-modified peptides from RAG-1.  Percent 
relative intensity is plotted as a function of mass:charge ratio.  Spectra obtained from H3K4me3-
treated samples are shown above the midline in red; spectra obtained from H3K4me30-treated 
samples are reflected below the midline in gray.  Sequences of the corresponding peptides and 
their charges (z) are given at upper right.  The heavy-modified peak is separated from the light-
modified peak by 6 daltons (Δ6). Images of mass spectra were generated in mMass Niedermeyer 
et al., 2012). 
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alkylated by mBBr-d6.  The mass spectra on the right indicate the 13C isotopologues of 
the same tryptic peptide, in which CP has been alkylated by light mBBr or mBBr-d6.  
Such a pattern would be expected if the addition of H3K4me3 were to alter the 
conformational distribution of RAG so as to increase the accessibility of residue CP to 
solvent.  
Tryptic peptides containing cysteine residues alkylated by light mBBr were 
identified by a mass shift of 190.20 Da relative to the unmodified form; peptides 
modified by mBBr-d6 exhibited the expected mass shift of 6.05 relative to their light 
modified counterparts.  Differences in the patterns of mBBr alkylation obtained in the 
presence of H3K4me3 or H3K4me0 were observed for several cysteine-containing 
peptides from RAG-1 (Fig 3.3 B – E).  For example, a tryptic peptide spanning residue 
C431 exhibited robust alkylation by light mBBr in the presence of H3K4me3 (Fig 3.3 B, 
upper panel, red) but was nearly refractory to alkylation by light mBBr in the presence of 
H3K4me0 (Fig 3.3 B, lower panel, gray).  The extent of alkylation by heavy mBBr 
following denaturation of RAG was similar in the presence of H3K4me0 or H3K4me3 
(Fig 3.3 B).  Representative mass spectra corresponding to peptides spanning C467, C478 
and C796 of RAG-1 also exhibited apparent differences between the H3K4me3 and 
H3K4me0 spectra with respect to alkylation by light mBBr (Fig 3.3 C – E).   
Differential footprinting with mBBr and mBBr-d6 provided a robust means to 
quantify the extent of pulse alkylation and to compare the efficiencies of pulse alkylation 
in samples that had been treated with H3K4me3 or H3K4me0.  This was achieved in 
three steps.  First, spectra representing all detectable peptides spanning a particular 
cysteine residue CP were binned.  Second, the peak intensities for all tryptic peptides 
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containing CP were summed over retention time and over the 13C isotopologues 
corresponding to heavy or light alkylation (ΣCP.H and ΣCP.L, respectively; Fig 3.3 A, 
bottom).  Third, the relative accessibility of each modified cysteine residue to light mBBr 
was defined as LC/(LC + HC), where L is ΣCP.L and H is ΣCP.H.  Three independent pulse 
alkylation-mass spectrometry assays were carried out for wild-type RAG and the mutant 
RAG preparation.   
The relative accessibility of RAG-1 cysteine residues to pulse alkylation in a 
native protein preparation incubated with the H3K4me0 control showed good correlation 
with the computed solvent-accessible area of cysteine residues in two available RAG 
structures (Kim 2015,Ru 2015) (Fig 3.4). We noted that the accessibility of RAG-1 C431 
to pulse alkylation was more closely correlated with its solvent-accessible area in the 
electron microscopic structure (Ru 2015) than in the crystallographic structure (Kim 2015), 
suggesting that the former structure may more closely approximate the predominant 
solution conformation of the NBD in the absence of H3K4me3
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Figure 3.4. Accessibility of RAG cysteine thiols to mBBr compared with accessible surface 
areas computed from structural data. A. Effective accessible surface areas (ASA) of cysteine 
residues in RAG-1 (dark gray bars) were computed from a cryoelectron microscopic structure 
of RAG (PDB ID code 3JBW) (20) using PISA as described in Experimental Methods. 
Relative accessibility to mBBr (light gray bars) was determined experimentally and is 
equivalent to L/(L + H) as defined in Experimental Methods. B. Correlation between effective 
ASA as computed in A with relative accessibility to mBBr. C. Effective accessible surface 
areas (ASA) of cysteine residues in RAG-1 (dark gray bars) were computed from an X-ray 
crystallographic structure of RAG (PDB ID code 4WWX) (11) using PISA as described in 
Experimental Methods. Relative accessibility to mBBr (light gray bars) is as defined in A. D. 
Correlation between effective ASA as computed in C with relative accessibility to mBBr. E. 
Effective ASA of cysteine residues in RAG-2 (dark gray bars) were computed from an X-ray 
crystallographic structure of RAG (PDB ID code 4WWX) (11) using PISA as described in 
Experimental Methods. Relative accessibility to mBBr (light gray bars) was determined 
experimentally and is equivalent to L/(L + H) as defined in Experimental Methods. F. 
Correlation between effective ASA as computed in E with relative accessibility to mBBr. The 
point corresponding to residue C350 (circled) was excluded from analysis because its high 







(Fig 3.4, A – D).  Alkylation of RAG-2 cysteine residues could only be compared to the 
solvent accessible areas computed from the crystallographic structure, because the 
electron microscopic structure employed zebrafish RAG-2, which is highly divergent 
from murine RAG-2. The only large discrepancy we observed between accessibility to 
pulse alkylation and computed effective surface area was at C350 of RAG-2, which was 
inaccessible to mBBr in the native state but exposed in the crystal structure (Fig 3.4, E 
and F).  This difference is likely explained by the fact that the X-ray structure was 
determined using a truncated form of RAG-2 in which the carboxy-terminal residues 
beyond C350 were disordered, while our pulse alkylation assays were performed with 
full-length RAG-2.   
H3K4me3 binding to the RAG-2 PHD finger is associated with solvent accessibility 
changes in RAG-1  
For RAG-1 in complex with wild-type RAG-2, peptides spanning 10 of the 15 
cysteine residues in cR1ct were consistently detectable.  For each of these peptides, the 
relative accessibility, LC/(LC + HC), of each detectable cysteine residue in the presence of  
H3K4me3 (Fig 3.5 A, red bars) was compared to its relative accessibility in the presence 
of H3K4me0 (Fig 3.5 A, gray bars).  Significant increases in accessibility of cysteine to 
alkylation by mBBr were observed at four positions: 431, 467, 478 and 796.  No 
significant decreases in relative accessibility were associated with H3K4me3 treatment.  
The effect of H3K4me3 on accessibility is depicted alternatively in Fig 3.5 B as the 
difference between the mean relative accessibility measured in the presence of 
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Figure 3.5.  Binding of H3K4me3 to the PHD of RAG-2 induces localized conformational 
changes in RAG-1.  A. Relative accessibility [L/(L+H)] of RAG-1 cysteine thiols to pulse 
alkylation by light mBBr in the presence of wild-type RAG-2 and H3K4me3 (red) or H3K4me0 
(gray).  Residues are numbered below.  Values indicate mean and S.E.M. of three trials.  
Statistical significance was determined by ANOVA.  *,  P < 0.05; **, P < 0.01; ***, P < 0.001.  
B.  Differential mean relative accessibilities ([L/(L+H)]me3 - [L/(L+H)]me0) of RAG-1 
cysteine thiols in wild-type RAG complexes pulse alkylated in the presence of H3K4me3 or 
H3K4me0.  Residues are numbered below.  C.  Relative accessibility [L/(L+H)] of RAG-1 
cysteine thiols to pulse alkylation by light mBBr in the presence of RAG-2(W453A) and 
H3K4me3 (red) or H3K4me0 (gray).  Residues are numbered below.  Values indicate mean and 
S.E.M. of three trials.  Statistical significance was determined by ANOVA and indicated as in 
(A).  D. Differential mean relative accessibilities ([L/(L+H)]me3 - [L/(L+H)]me0) of RAG-1 
cysteine thiols in complexes containing RAG-2(W453A), pulse alkylated in the presence of 






H3K4me3 ([LC/(LC + HC)]me3) and that measured in the presence of H3K4me0 ([LC/(LC 
+ HC)]me0).  These results indicate that several cysteine thiols in RAG-1 exhibit 
increased susceptibility to alkylation by mBBr in the presence of H3K4me3. H3K4me3 
exerts its allosteric effects on DNA binding and catalysis through an interaction with the 
PHD finger of RAG-2.  To determine whether the effects of H3K4me3 on alkylation of 
RAG-1 are similarly mediated, we performed differential footprinting with RAG 
complexes containing the RAG-2 W453A mutation, which disrupts binding of the PHD 
finger to H3K4me3.  The W453A mutation abolished the ability of H3K4me3 to enhance 
alkylation by mBBr at each of the positions where enhanced alkylation was observed in 
the wild-type complex (Fig 3.5 C and D).  Taken together these observations indicate that 
engagement of H3K4me3 by the PHD finger of RAG-2 is communicated to the RAG-1 
subunit as an alteration in the distribution of RAG-1 conformations.   
H3K4me3-induced changes in mBBr accessibility not detected in the RAG-2 core 
region 
Peptides spanning 11 of the 17 cysteine residues in full-length, wild-type RAG-2 
were consistently detected.  Of these cysteine residues, eight lie within the RAG-2 core 
region and three within the PHD finger; residues from the highly acidic autoinhibitory 
region were inconsistently detected.  Residues C114, C191 and to a lesser extent C350 
were pulse alkylated by light mBBr in the absence of H3K4me3; no significant changes 
in the extent of alkylation at these or other cysteine residues were observed in the 
presence of H3K4me3 (Fig 3.6A, B).  The W453A mutation had no effect on the 
accessibility of RAG-2 core residues to mBBr in the presence of either H3K4me3 or 
H3K4me0, but was associated with a large increase in basal alkylation of C446 and 
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C478, which reside within the PHD finger.  The apparent increase in solvent accessibility 
of these residues is consistent with a destabilizing effect of the W453A mutation on the 
PHD finger (Fig 3.6 C, D).  
 
Figure 3.6. Accessibility of RAG-2 cysteine thiols to mBBr in the presence of H3K4me3 or 
H3K4me0.  (A) Relative accessibility [L/(L+H)] of wild-type RAG-2 cysteine thiols to pulse 
alkylation of RAG tetramers by light mBBr in the presence of H3K4me3 (red) or H3K4me0 
(gray). Residues are numbered below. Values indicate mean and S.E.M. of three trials. No 
significant differences (ANOVA) were observed at the cysteine residues detectable by LC-
MS. (B) Differential mean relative accessibilities ([L/(L+H)]me3 - [L/(L+H)]me0) of RAG-2 
cysteine thiols in wild-type RAG complexes pulse alkylated in the presence of H3K4me3 or 
H3K4me0. Residues are numbered below. (C) Relative accessibility [L/(L+H)] of RAG-
2(W453A) cysteine thiols to pulse alkylation of RAG tetramers by light mBBr in the presence 
of H3K4me3 (red) or H3K4me0 (gray). Residues are numbered below. Values indicate mean 
and S.E.M. of three trials. No significant differences (ANOVA) were observed at the cysteine 
residues detectable by LC-MS. (D) Differential mean relative accessibilities ([L/(L+H)]me3 - 
[L/(L+H)]me0) of RAG- 2(W453A) cysteine thiols in RAG complexes pulse alkylated in the 






We considered the possibility that the alterations in cysteine alkylation induced by 
H3K4me3 might result from changes in the association of RAG-1 with RAG-2, rather 
than alterations in the conformation of tetrameric RAG.  One argument against a 
H3K4me3-dependent change in the distribution of RAG multimers, however, comes from 
a consideration of the pulse alkylation data for RAG-2.  The available RAG structures 
(11, 20) locate Cys41 and Cys67 of RAG-2 at an interface with RAG-1.  We detected no 
H3K4me3-dependent solvent accessibility changes at either of these residues, as would 
have been expected from an alteration in the association of RAG-2 with RAG-1, and both 
residues remain relatively inaccessible to mBBr in the presence of H3K4me0 or 
H3K4me3 (Fig 3.6 A, B).  Two additional lines of evidence support this interpretation.  
First, the active fraction of wild-type RAG, as assessed by burst kinetic analysis, was 





 Second, electrophoretic mobility shift assays typically resolve two discrete RAG-DNA 
complexes, each containing a RAG-1 dimer and one or two RAG-2 subunits (Swanson 
2002); we observed no difference in the relative yields of these complexes in the presence 
of H3K4me0 or H3K4me3 (Fig 3.8).  These observations suggest that under the 
conditions of these assays the introduction of H3K4me3 is unaccompanied by an 




Figure 3.7 H3K4me3 does not alter the 
active fraction of RAG as determined by 
burst kinetic analysis. A.  Burst kinetic 
analysis of wild-type RAG. A complex of 
cRAG-1ct with full-length, wild-type 
RAG-2 was assayed for nicking of a 12-
RSS substrate at various nominal RAG 
concentrations in the presence of 
H3K4me3 or H3K4me0. Accumulation of 
nicked product was assayed at 5, 10, 15, 
and 20 min. N, nicked product. B. 
Accumulation of nicked product in the 
presence of H3K4me0 is plotted as a 
function of time at each nominal RAG 
concentration as indicated in the inset. C.  
Accumulation of nicked product in the 
presence of H3K4me3 is plotted as a 
function of time at each nominal RAG 
concentration as indicated in the inset. D. 
Estimation of the active fraction. Kinetic 
curves of B and C were extrapolated to zero 
time to give the [N]0 associated with each 
nominal RAG concentration ([RAG]). 
[N]0 was then plotted as a function of 
[RAG]; the slope of each resulting curve 





 The active fraction of the RAG preparations employed above, as assessed by burst 
kinetic analysis, was only about five percent, likely a result of the harsh sonication 
employed to remove H3K4me3.  We sought a way to obtain a more active preparation of 
RAG with which to assess the effects of H3K4me3 on conformation.  By avoiding 
sonication and introducing a mild DNase treatment prior to amylose affinity purification, 
we were able to obtain RAG free from detectable H3K4me3 and residual DNase activity 
Figure 3.8 H3K4me3 does not alter the distribution of RAG–RSS complexes as assessed by 
electrophoretic mobility shift. A. Electrophoresis mobility shift assay (EMSA) for wild-type 
RAG-2/cRAG1-ct binding to a radiolabeled consensus 12-RSS DNA substrate, in the presence 
of increasing concentrations of H3K4me0 or H3K4me3 peptide. RAG (0.3 μM) was incubated 
with 1 nM 12-RSS probe and H3K4 peptide (0.5–4 μM) for 30 min at 37 °C. After addition of 
4 μL 50% (vol/vol) glycerol, reactions were resolved on a 4% (vol/vol) acrylamide gel. B. Ratio 
of SC1:SC2 as a function of H3K4me0 concentration. C. Ratio of SC1:SC2 as a function of 





(Fig 3.9, A and B).  The activity of this preparation, as assessed by burst kinetic analysis, 
was about 24 percent (Fig 3.9, C and D).   
This more active fraction exhibited H3K4me3-induced changes in mBBr accessibility 
similar to those observed for the less active fraction (Fig 3.9 E), indicating that the 
conformational alterations we detected with the sonicated preparations were not an 
artifact of the mode of purification.  This result, moreover, suggests that some portion of 
inactive RAG, as defined by burst kinetic analysis, retains the ability to undergo 




Figure 3.9 Assay for altered solvent accessibility in RAG prepared by a gentle method. (A) 
Assay for RAG-1, RAG-2, and H3K4me3 at various stages of purification by immunoblotting. 
(Upper) Detection of RAG using an anti-MBP antibody. (Lower) Immunoblotting with an anti-
H3K4me2/3 antibody. E, eluate; Ins, insoluble fraction; WCL, whole-cell lysate; W2, wash 2; 
and W4, wash 4. (B) Purified RAG is free of detectable DNase contamination. Selected RAG 
purification fractions were incubated with radiolabeled substrate HL44/45 for 1 h at 37 °C. 
DNase was assayed in the indicated amounts and a standard sonicated RAG preparation was 
used as a negative control. E, eluate; W1, wash 1; and W4, wash 4. (C and D). Burst kinetic 
analysis of gently purified RAG. Active fraction was determined to be 23.6%. (E) Relative 
accessibility [L/(L + H)] of RAG-1 cysteine thiols to pulse alkylation by light mBBr in the 
presence of gently purified wild-type RAG-2 and H3K4me3 (red) or H3K4me0 (gray). 
Residues are numbered below. Values indicate mean and SEM of three trials. Statistical 
significance was determined by ANOVA. *P < 0.05; **P < 0.01. (F) Differential mean relative 
accessibilities ([L/(L + H)]me3 − [L/(L + H)]me0) of RAG-1 cysteine thiols, pulse alkylated in 






H3K4me3-induced conformational changes in RAG-1 and RAG-2 mapped by 
limited proteolysis and LC-MS/MS 
We used limited proteolysis in combination with LC-MS/MS to confirm that 
H3K4me3 binding to the RAG-2 PHD finger is associated with conformational changes 
in RAG.  We chose thermolysin for this purpose because of its relatively low specificity, 
which would increase the likelihood of identifying cleavage sites whose accessibility was 
altered upon binding of H3K4me3.  Moreover, the use of thermolysin was expected to 
promote detection of peptides from regions with a paucity of tryptic cleavage sites, in 
particular the RAG-2 autoinhibitory domain.  RAG complexes containing wild-type 
RAG-2 or RAG-2(W453A) were incubated with thermolysin for various times in the 
presence of H3K4me3 or H3K4me0.  The mass distribution of partial proteolytic 
fragments obtained from wild-type RAG in the presence of H3K4me3 differed from the 
distribution obtained in the presence of H3K4me0, in that H3K4me3 enhanced 
production of fragments migrating at about 85 kD and 60 kD (Fig 3.10, arrows).  In 
contrast, the proteolytic pattern observed for the mutant RAG complex in the presence of 
H3K4me3 was similar to the pattern obtained in the presence of H3K4me0 (Fig 3.10 A), 
indicating that the effect of H3K4me3 on proteolysis was dependent on an interaction 
with the PHD finger.   The fragments whose production was stimulated by H3K4me3 
were excised, subjected to digestion with Lys-C and identified by LC-MS/MS.  Sites of 
thermolysin cleavage were determined by comparison to reference spectra obtained for 
RAG digested with Lys-C alone.  The 85 kD band was produced by thermolysin cleavage 
of RAG-2 at two neighboring sites, F384 and F386 (Fig 3.10 A, B).  The resulting amino-







B), which is predicted to yield carboxy-terminal fragments of 62.21 and 62.32 kD, once 
again consistent with the observed mobilities.    
Localization of H3K4me3-induced conformational changes to DNA-binding, 
catalytic and autoinhibitory domains of RAG 
RAG-1 contains six discrete structural domains (Kim 2015,Yin 2009).  Of the four 
cysteine residues of RAG-1 that exhibit increased solvent accessibility upon H3K4me3 
binding, three reside in domains responsible for RSS recognition: C431 lies in the 
nonamer binding domain (NBD) (Fig. 5A and C) while C467 and C478 lie in the 
dimerization and DNA-binding domain (DDBD) (Fig. 5B and D).  The fourth residue, 
C796, resides in the ZnH2 domain (Fig. 5A and E), which acts as a scaffold for the 
catalytic region (Kim 2015).  The sites in RAG-1 at which H3K4me3 enhances 
thermolysin cleavage, I496 and F497, also reside in the DDBD, providing additional 
evidence for an allosteric conformational change in this domain (Fig 3.10 B). F384 and 
F386 lie within the acidic autoinhibitory domain of RAG-2 (3.10 B), which is not 
contained within the available structures (Kim 2015, Ru 2015, Yin 2009).  The ability of 
H3K4me3 to promote proteolysis at these sites indicates that allosteric activation of 
RAG-2 is accompanied by increased accessibility of the autoinhibitory domain to 
thermolysin.  This change in conformation may reflect disruption of an inhibitory 
interaction that suppresses RAG activity, as we previously demonstrated that mutation of 
the RAG-2 autoinhibitory domain mimics the stimulatory effects of H3K4me3 on RSS 




























Figure 3.11 Localization of H3K4me3-dependent conformational changes to sites of DNA 
binding and catalysis in RAG-1.  A. Locations of C431 and C476 in the NBD and ZnH2 
domain, respectively, of RAG-1.  The structure (Kim et al., 2015) was depicted from 
coordinates deposited in Protein Data Bank under accession code 4WWX.  Only the RAG-1 
chains are shown.  Domains are labeled as defined in Fig. 4B.  B.  The RAG-1 dimer in (A) is 
rotated horizontally approximately 180˚ to display the locations of C467 and C478 in the 
DDBD.  Domains are labeled as defined in Fig. 4B.  C. H3K4me3-induced increase in solvent 
accessibility at C431, which lies at the NBD dimerization interface.  D. H3K4me3-induced 
increases in solvent accessibility within the RAG-1 DDBD.  C467 and C478 lie in two helical 
bundles that comprise a portion of the RSS heptamer binding site.  E.  The RAG-1 catalytic 
center.  The residues that comprise the catalytic motif - D600, D708, and E962 - are 
highlighted in red.  C796 lies within one of the helices of the ZnH2 domain, which bridges 













cleavage (Lu 2015).  In this regard it has been suggested (Liang 2002) that the RAG-2 
non-core region stabilizes the association of RAG-1 with RAG-2 through an interaction 
with the DDBD of RAG-1.  A speculative notion, which remains to be tested, is that the 
acidic autoinhibitory domain enjoys an association with the DDBD through charge-
charge interactions, impairing RSS binding until inhibition is relieved by H3K4me3  
Here we have favored the conservative interpretation that H3K4me3-induced changes in 
solvent accessibility represent changes in RAG conformation induced by occupancy of 
the PHD finger.  A narrower interpretation is that the observed changes in solvent 
accessibility reflect exposure of residues that are occluded by the PHD finger in the 
absence of H3K4me3.  While this interpretation is consistent with the available data, it 
seems unlikely that that all of these solvent accessibility changes occur at sites of direct 
contact with the PHD finger, because they occur in three separate regions of the RAG-1 
surface – the NBD, the DDBD and the ZnH2 domain.   
Allosteric regulation by epigenetic marks 
Other enzymes in addition to RAG are subject to control by chromatin 
modifications.  The histone methyltransferase polycomb repressive complex (PRC)2 is 
activated by binding of H3K27me3 to a WD40 propeller in the EED subunit (Byrum 
2015), while the histone acetyltransferase Tip60 is stimulated by an interaction between 
its chromodomain and H3K9me3 (Margueron 2009).  The DNA methyltransferase 
Dnmt3a, like RAG, is activated through a PHD finger, although in the case of Dnmt3a 
the allosteric ligand is H3K4me0 (Sun 2009).  In none of these instances is it known how 
information regarding occupancy of the allosteric regulatory site is propagated within the 
protein.  In Dnmt3a, mutations that impair allosteric activation but preserve binding to 
61 
 
H3K4me0 have been identified at a putative interface between the PHD and catalytic 
domains (Sun 2009), suggesting that propagation of the allosteric signal involves a direct 
interaction between these regions.   
Evidence presented here indicates that a signal initiated by binding of H3K4me3 
to the RAG-2 PHD is propagated to the RAG-2 autoinhibitory domain as well as to the 
DNA-binding and catalytic regions of RAG-1, but the pathways by which this signal is 
transmitted is unknown.  Specifically, it is unclear whether allosteric signal transmission 
involves direct contact between the RAG-2 PHD and the catalytic or DNA-binding 
domains of RAG-1.  Because available structures of RAG do not include the PHD or 
autoinhibitory regions of RAG-2 (Kim 2015, Ru 2015), it is not yet known where these 
domains lie relative to the sites of H3K4me3-induced conformational change in RAG-1.   
Implications for coupling of V(D)J recombination to transcription 
Initiation of V(D)J recombination is coupled to the lineage- and developmental 
stage-specific activation of transcription at specific antigen receptor loci.  This coupling 
underlies the ordered rearrangement of heavy- and light-chain genes during lymphocyte 
development and provides a means by which Ig and TCR expression are restricted to the 
B- and T-lymphoid lineages, respectively.  Transcriptional activity at antigen receptor 
loci is positively correlated with the local deposition of H3K4me3 (Li 2011), and the 
ability of H3K4me3 to serve as an allosteric activator of RAG suggests a molecular 
mechanism by which transcription and recombination are coupled.  H3K4me3 in itself is 
insufficient, however, to establish locus specificity, as this epigenetic mark is enriched 
near all active promoters (Perkins 2004).  Indeed, the distribution of RAG-2 in chromatin 
is positively correlated with the density of H3K4me3 (Barski 2007). The required 
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specificity could, in principle, be provided by combined recognition of H3K4me3 and 
one or more RSSs, although the participation of an additional ligand distinct from 
H3K4me3 remains possible.  Results presented here suggest a sequential process of site 
specification in which the binding of H3K4me3 to the RAG-2 PHD induces 
conformational changes in the DNA-binding domains of RAG-1 that confer increased 
affinity for RSSs. The RAG heterotetramer contains two subunits each of RAG-1 and 
RAG-2.  It is not known whether both PHD fingers must be occupied by H3K4me3 to 
effect allosteric activation, nor is it known whether the stimulatory effects of H3K4me3 
on RSS binding and catalysis are exerted in cis or in trans, with respect to RAG-1.  
Answers to these questions will be critical to an understanding of how synapse formation 
and cleavage occur in the context of active chromatin. 
Off-target RAG activity at cryptic cleavage sites is restricted to chromatin loop 
domains containing paired, canonical RSSs, and these off-target events are directionally 
oriented relative to the RSS ends (Hu 2015).   These observations have suggested a 
directional sampling mechanism in which one canonical RSS in a paired complex 
dissociates from active RAG, allowing capture of a downstream cryptic RSS. While the 
mechanism underlying directional sampling by RAG is unknown, theoretical and 
experimental considerations (Hu 2015, Marcovitz 2013) suggest that RAG may assume 
distinct conformations in sampling mode and in its various RSS binding modes.  If so, 
this suggests that H3K4me3 may modulate the transition from tracking to RSS capture by 






Pulse alkylation  
Pulse alkylation was based on a published procedure (Chen 2012).  RAG (0.5 µg 
active heterotetramer as determined by burst kinetic analysis) was incubated in in buffer 
R [25 mM HEPES (pH 7.4), 150 mM KCl, 0.5 mM DTT, 1 mM CaCl2 and 10% glycerol] 
and 20 µM H3K4me3 or 20 µM H3K4me0 for 30 min at 37°C.  Monobromobimane 
(mBBr) was added to 1mM.  After 1 min at 37°C, alkylation was quenched by the 
addition of 10 mM β-mercaptoethanol and incubation was continued for 2 min to permit 
scavenging of unreacted mBBr. After quenching, protein was denatured by addition of 
guanidinium chloride (GdmCl) to 6M.  Hexadeuterated mBBr (mBBr-d6) was added to 
20 mM and samples were incubated for 2 hr at 37°C to permit alkylation of unreacted 
cysteines with mBBr-d6.  Protein was dialyzed into 20 mM HEPES, 20% ACN, 5 mM β-
mercaptoethanol, isolated by SDS page gel electrophoresis and visualized by staining 
with Coomassie blue.  RAG-1 and RAG-2 were excised and in-gel digestion was carried 
out with trypsin and V8 protease in 50mM ammonium bicarbonate and 1% surfactant 
(ProteaseMax, Promega) as described (Shevchenko 2006).  Peptides were extracted with 
2:1 acetonitrile: 5% formic acid, lyophilized, resuspended in 0.1% trifluoroacetic acid 
and concentrated by C18 adsorption chromatography.  Peptide samples were 







Mass spectrometry data analysis and quantification 
MS/MS spectra were searched against a customized database composed of wild-
type RAG-1, wild-type RAG-2, RAG-2(W453A) and 248 common contaminant proteins 
using the SEQUEST search algorithm (Proteome Discoverer 1.4, Thermo Scientific).  
Cleavage by either trypsin or endoproteinase Glu-C was examined; a maximum of six 
missed cleavages were allowed.  Alkylation of cysteine by mBBr or mBBr-d6 and 
oxidation of methionine were included as dynamic modifications.  The minimum peptide 
length was set at 6 residues. The mass tolerances were set to 10 ppm. and 0.02 Da for 
precursor and fragment ions, respectively.  Matched spectra were filtered using the 
Percolator algorithm (Proteome Discoverer).  Peptide identifications were called at 
a q value <0.01.  
Cysteine alkylation by mBBr and mBBr-d6 was quantified using a custom 
program coded in R (http://www.R-project.org/).  Peptides were binned first according to 
the presence of cysteine and then according to the position of the cysteine in the RAG-1 
or RAG-2 protein sequence. For each cysteine residue in RAG-1 or RAG-2, the total 
peak area, LC or HC, for all light-modified or heavy modified peptides was obtained by 
summation over all 13C isotopologues and all sequential liquid chromatography samples 
in which the peptide was detected: 
∑ 𝐶(𝑝, 𝐿)𝑛𝑝=0  ≡ LC and  ∑ 𝐶(𝑝, 𝐻)𝑛𝑝=0 ≡ HC, 
where C is the peptide corresponding to a specific cysteine residue in the RAG-1 or 
RAG-2 sequence, p denotes an individual MS peak corresponding to that residue, LC 
denotes alkylation of residue C by mBBr and HC denotes alkylation of residue C by 
mBBr-d6.  The relative accessibility of each modified cysteine residue to light mBBR, 
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which is interpreted to indicate solvent accessibility in one or more conformational states, 
was determined by: 
LC/(LC + HC). 
The change in accessibility of a particular cysteine residue associated with the 
introduction of the plant homeodomain ligand H3K4me3 is then: 
[LC/(LC + HC)]me3 - [LC/(LC + HC)]me0, 
where the subscripts me3 and me0 specify relative accessibility in the presence of 
H3K4me3 and H3K4me0, respectively. 
Cell culture 
HEK 293T cells were grown in Dulbecco’s Modified Eagle Medium (DMEM) 
lacking pyruvate and supplemented with 10% fetal bovine serum and 1X penicillin-
streptomycin-glutamine (Life Technologies). Cells were maintained at 37°C in 5% CO2. 
Expression constructs  
 
DNA fragments encoding full length wild-type RAG-2 and RAG-2(W453A) were 
PCR amplified and ligated into pcDNA3.1, in frame with a cassette encoding an amino-
terminal MBP tag and a carboxy-terminal tobacco etch virus protease site (MBP-TEV).  
To generate an MBP tagged form of cR1ct, a DNA fragment encoding amino acid 
residues 384-1040 of RAG-1 was cloned into pcDNA 3.1 in frame with an amino 







Purification of RAG proteins 
Maltose binding protein (MBP) fusions to full length wild-type RAG-2, RAG-
2(W453A), or amino acid residues 383-1040 of RAG-1 (cRAG1-ct) were coexpressed in 
293T cells and purified by amylose affinity chromatography as described (Lu et al., 
2015).  The active fraction of each RAG protein preparation was determined by burst 
kinetic analysis as described (Lu et al., 2015).  Equivalent molar amounts of active RAG, 
as determined by burst kinetic analysis, were compared in coupled DNA cleavage and 
pulse alkylation mass spectrometry assays.  
Oligonucleotide substrates  
The double-stranded oligonucleotide substrates HL-44/45 (12-RSS) and HL-
46/47 (23-RSS) were prepared as described (Shimazaki et al., 2012).  The 5’ end of 
oligonucleotide HL-44 was radiolabeled with 32P by T4 DNA polynucleotide kinase 
(New England Biolabs) before annealing to HL-45.  Duplex oligonucleotides were 
purified by gel electrophoresis. 
Assays for coupled DNA cleavage 
Coupled cleavage assays were performed as described (Lu et al., 2015).  
Equivalent amounts of active wild-type or mutant RAG tetramer (1 nM), as determined 
by burst kinetic analysis, were incubated with 5 nM 32P-labeled HL44/45 substrate, 5 nM 
unlabeled HL46/47 substrate and varying amounts of H3K4me3 or H3K4me0 peptide in 
10 µL reaction buffer (25 mM 3-(4-Mopholino)propane sulfonic acid-KOH pH 7.0, 
30mM KCl, 30 mM potassium glutamate, 5 mM CaCl2, 0.5 mM DTT, 0.1 mg/mL BSA, 
1% glycerol).  After 20 min at 37°C, MgCl2 was added to 5 mM and incubation was 
continued for 1 hr.  Reactions were stopped by addition of loading buffer (90% 
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formamide, 0.2% bromophenol blue) and incubation at 90°C for 2 min. Products were 
seperated on a 15% polyacrylamide-urea gel, analyzed on a phosphor imager, and 
quantified using ImageQuantNL.  
Liquid chromatography-mass spectrometry 
Peptide samples were reconstituted in 10% formic acid and analyzed by mass 
spectrometry (MS) on a linear trap quadrupole (LTQ)-Orbitrap Elite mass spectrometer 
(Thermo Electron), coupled to a nanoflow liquid chromatography system (Easy-nLCII, 
Thermo Scientific).  Peptides were resolved on a C18 analytical column (75  m × 60 cm, 
5 µm particle size) at a flow rate of 250 nl min−1 using a linear gradient of 7% – 35% 
solvent B (0.1% formic acid, 95% acetonitrile) over 65 min.  Spectra were acquired with 
full scans (300 – 1,700 m/z) using the Orbitrap mass analyzer at a mass resolution of 
120,000 at 400 m/z.  The ten most intense precursor ions from a survey scan were 
selected for tandem mass spectrometry (MS/MS) from each duty cycle. The selected 
precursor ions were fragmented by higher-energy collision dissociation and detected at a 
mass resolution of 30,000 at 400 m/z.  Dynamic exclusion was set for 30 sec with a 
10 ppm mass window. The automatic gain control was set to 1 million for full Fourier 
transform (FT) MS and to 0.05 million for FT MS/MS, with maximum ion injection 
times of 100 ms and 300 ms, respectively.  Internal calibration was carried out using lock 
mass from ambient air (m/z 445.1200025).  Mass spectroscopic images were generated 







RAG was preincubated with H3K4me3 or H3K4me0 in buffer R as described for 
pulse alkylation, except that CaCl2 was added to 0.5mM.  Thermolysin (Promega) was 
added at a protein mass ratio of 1:20 thermolysin:RAG and incubation was continued at 
37°C for 15 min. Samples were removed at 5, 10, and 15 min and reactions were stopped 
by heating to 100°C in SDS PAGE loading buffer containing 50 mM EDTA.  Products 
were fractionated by 9% SDS PAGE, detected by staining with Coomassie blue, excised 
and digested with either trypsin (Promega) or Lys-C (Promega).  Peptides were analyzed 
by LC-MS/MS as described above for PA-MS. Thermolysin cleavage sites were 
determined by first comparing peptides from the thermolysin partial proteolysis band to 
control RAG-1 and RAG-2 proteins digested with the secondary protease (trypsin or Lys-
C), and identifying unique peptides present in only the partial proteolysis band, that begin 
or terminate in an N-terminal cleavage to one of amino acids: F,V,L,I,A, or M. 
Accessible surface area calculations 
Accessible surface areas of cysteine residues in RAG were calculated using the 
Protein interfaces, surfaces and assemblies (PISA) of the European Bioinformatics 
Institute (http://www.ebi.ac.uk/pdbe/prot_int/pistart.html), using available structures of 






Supplement: Identifying the RAG-1/RAG-2 allosteric 




PmB TGYWIKCSPTCNVNINIWVPYYSTEFNKPAMIFCSSGGDDGHWVHAQCMDLTESQLIQFSQENTKYFCKEHH IA 
Pun TGYWIKCSSACNMNVNIWEPYYSTELNKPAMIFCSSGGDDGHWVHAQCMNLAESQLIQFSQENTKYFCNEHY IA 
Mus  TGYWITCCPTCDVDINTWVPFYSTELNKPAMIYCSHG   GHWVHAQCMDLEERTLIHLSEGSNKYYCNEHVQIA 
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extends from 414 to 484 (Fig 4.1 A,B). To determine whether substitution of either the C. 
punctatum or C. plumbeus PHD finger disrupts RAG-2 mediated activation of RAG-1, 
we employed the PJH200 assay, which is an extrachromosomal assay for V(D)J 
recombination. Recombination was impaired by the substitution of the C. punctatum 
PHD finger into murine RAG-2, but was not significantly impaired by C. plumbeus (Fig 
4.2A).  Mutation of the critical tryptophan W456 within the PHD pocket, which ablates 
PHD-H3K4me3 interactions, did not significantly decrease the activity of C. punctatum 









misfolded protein, we purified C. punctatum and WT RAG-2 with cRAG1-CT, and tested 
them in a DNA cleavage assay. Both RAG-2 proteins were stimulated either with control 
H3K4me0 peptide, or H3K4me3, to determine if they were responsive to H3K4me3. As 
previously observed, the cleavage activity of WT RAG-2 in complex with cRAG-1-CT 
exhibited a dose dependent increase in DNA cleavage in response to H3K4me3 
stimulation (Fig 4.3). In contrast, the C. punctatum RAG-2 chimera exhibited a basal 
level of cleavage similar to that of WT RAG-2, but was unresponsive by H3K4me3.  
The C. punctatum RAG-2 chimera is competent to bind H3K4me3, exhibits a loss 
of function in vivo, and is active but unstimulable by H3K4me3 in an in vitro DNA 
cleavage assay, meeting the criteria for an allosterically null mutant of RAG-2. We 
predicted therefore that one or more of the nonconserved residues of the C. punctatum 
PHD which had been substituted into murine RAG-2 had disrupted the allosteric interface 
between RAG-1 and RAG-2. This suggests that reverting one or more of the substituted 
residues back to native murine sequence should rescue loss of function phenotype. We 
tested this hypothesis by back-mutating groups of 5-6 amino acids in the C. punctatum 




These back-mutated RAG-2 variants were then tested in the recombination assay, 
to determine whether any of these reversion mutations rescued the C. punctatum 
phenotype (Fig 4.5 A). In some repeats of this experiment, group 1 and group 2 reversion 
mutants both exhibited a partial restoration of RAG function; this suggested the interface 
M. Mus  TGYWITCCPTCDVDINTWVPFYSTELNKPAMIYCSHG---GHWVHAQCMDLEERTLIHLSEGSNKYYCNEHVQIA 






Figure 4.4 Reversion mutation of the C. punctatum RAG-2 chimera back to M. musculus 
sequence by group substitution. A. Sequence alignments of the M. musculus and C. punctatum 
PHD fingers, and the reversion mutants with shark-to-mouse back mutations highlighted. B. 
Top down view of the crystal structure of the RAG-2 PHD finger, with non-synonomous 
mutations between C. punctatum  and mouse highlighted in green. Red residues are conserved 
between mouse and shark, H3K4me3 is highlighted in Gray. C.  Mapping of the reversion 
mutant groups in the PHD finger. The green residues are now highlighted by reversion group 
color: Group 1- Blue, Group 2- Purple, Group 3- Yellow, Group 4- Teal, Group 5- Green. Note 
that although Group  5 substitutions are broadly distributed in primary sequence, they are tightly 









that transmits the allosteric signal from RAG-2 to RAG-1 may be bounded by both these 
groups of residues. We therefore generated a revertant mutant in which both group 1 and 
group 2 were back-mutated to murine sequence, and then assayed this variant for 
recombination. Reversion of both group 1 and group 2 residues rescued RAG activity to a 
level near that of WT, a rescue that was better than either group 1 or group 2 (Fig 4.5 B). 
These results suggest that the allosteric interface of RAG-2 is bounded between residues 











Antigen receptors are a canonical component of the mammalian immune system; 
these unique proteins recognize and target for elimination the innumerable foreign 
invaders that attack the body every day.  Underlying these proteins is V(D)J 
recombination, initiated by the RAG recombinase, which generates the primary diversity 
of the antigen receptor genes. Accessibility of antigen receptor genes to RAG is 
transcription dependent, and the presence of “active” chomatin marks such as H3K4 
trimethylation are positively correlated with the ability to undergo recombination. This 
accessibility hypothesis initially posited that the “openness” of the antigen receptor loci 
chromatin loci was the key element in driving recombination (Yancopoulos 1985). Our 
findings refine this observation, and provide a new model for regulation of nuclear 
enzymes by chromatin. The observation that the W453A nearly ablates recombination 
demonstrates that transcription of an antigen receptor locus is not sufficient to drive 
recombination, Rather, recombination requires coordination of locus accessibility with 
specific chromatin contacts with RAG that promote V(D)J recombination. Our in vitro 
characterizations of the effects of H3K4me3 on RAG activity indicate that engagement of 
the RAG-2 PHD finger with H3K4me3 has profound stimulatory effects on both the 
affinity of RAG for and RSS and DNA cleavage.  
Pulse alkylation studies carried out here provide the first direct evidence to 
explain these H3K4me3 changes in Kcat and KD. H3K4me3 stimulation of RAG is 
associated with increased solvent accessibility of the DNA binding domains of RAG-1, 
as well as the catalytic center. While not detected by pulse alkylation, concomitant 
increases in solvent exposure of the RAG-2 inhibitory domain was observed by partial 
proteolysis. These changes in solvent accessibility likely represent allosteric transitions 
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within the RAG complex. Allosteric regulation of proteins is a well-known phenomenon; 
allostery gates the activity of many important enzymes including members of kinase 
cascades, integrases, and a number of oncogenes. But epigenetic allosteric regulation of 
nuclear enzymes to this point have been largely unexplored 
Three lines of evidence support the interpretation that H3K4me3 is an allosteric 
regulator of RAG. First, an H3K4me3 peptide stimulates RAG in vitro, and in the 
absence of additional cofactors. Second, pulse alkylation mass spectrometry footprinting 
of the RAG proteins in the presence of H3K4me3 reveals that several domains of RAG-1 
exhibit a conformational changes upon H3K4me3 binding to the RAG-2 PHD finger. 
Third, RAG-2 mutants have been generated that are capable of binding H3K4me3 but 
unable to stimulate RAG-1 catalytic activity. These data are consistent with a model in 
which the inhibitory domain of RAG-2 occupies the DNA binding domain(s) of RAG-1, 
until such time that RAG-2 engages the H3K4me3 mark. In this model, engagement of 
RAG-2 with H3K4me3 would relieve inhibition of RAG-1, permitting enhanced DNA 
binding and cleavage.  
`  Although an allosteric change was detected in the RAG-2 AcID domain 
(Ward unpublished data) using limited proteolysis, this domain does not appear to be 
responsible for transmitting the allosteric binding signal from RAG-2 to RAG-1. Our 
mapping of the RAG-2 allosteric transmission site by least-common ancestor substitution 
indicates that non-synonomous mutations in a PHD finger from the C. punctatum shark 
RAG-2, when placed in the context of murine RAG-2, disrupts the allosteric transmission 
signal generated by binding H3K4me3. The C. punctatum RAG-2 PHD finger murine 
RAG-2 chimera was unable to support V(D)J recombination on an extrachromosomal 
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substrate (PJH200) but retained the ability to engage the H3K4me3 mark. This mutant 
was the first evidence that the ability of RAG-2 to bind H3K4me3 is not sufficient to 
stimulate RAG activity, and that localization of RAG-2 with H3K4me3 in the nucleus is 
not the primary function of the RAG-2 PHD finger. Selective reversion of non-
synonomous mutations within the C. punctatum PHD back to murine sequence rescued 
this loss of function phenotype, indicating that residues 417-433 of RAG-2 are 
responsible for transmission of the allosteric signal from RAG-2 to RAG-1. Structural 
mapping of these mutations make physiological sense, as these residues form an interface 
on the exterior of the RAG-2 PHD finger, directly above the H3K4me3 binding pocket. 
These data strongly argue against H3K4me3 as a mere localization signal for RAG-2. 
Instead, the critical role of the PHD finger appears to be to impart these allosteric changes 
to the RAG complex as a whole upon binding H3k4me3. These data further reinforce the 
model that H3K4me3 allosterically regulates RAG through the RAG-2 PHD finger.  
Parallel work to this thesis by Ward and others (Liu 2015 and unpublished data) 
revealed the existence of an “AcID” (acidic inhibitory domain) region within RAG-2 that 
when mutated, can bypass RAG’s dependence on H3K4me3, rescuing the W453A 
phenotype. This initially suggested that the activity of these domains might be linked. 
However, the AcID domain can act independently of the PHD finger, although the two 
domains do appear to have direct contacts (Ward unpublished data). Still, the exact nature 
of the interplay between the AcID domain and the PHD finger of RAG-2 warrant further 
study.  
Allosteric regulation of proteins by chromatin may be a more general 
phenomenon of nuclear enzyme complexes. Many nuclear enzyme complexes contain a 
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subunit capable of recognizing one or more post translational modifications. Allosteric 
gating of these enzyme complexes would provide a means to suppress activity, until such 
a time when they encounter their allosteric stimulating chromatin mark, thereby limiting 
off target activity. While this hypothesis remains to be tested, it is interesting to speculate 

















Supplementary Experimental Methods:  
RAG-2 Pulldowns 
10 µg MBP Shark chimera RAG-2 (Either C. punctatum or C. plumbeus) were 
transfected into HEK-293T cells plated at 2*106 cells/plate, using the PEI. 48 hours post 
transfection cells were harvested in ice cold PBS containing 2mM EDTA, and cells were 
pelleted at 500Xg for 5 minutes. Pellets were resuspended in 500µL lysis buffer 
(50mMTris (pH 7.5), 300mMNaCl, 1 mMPMSF,1%NP-40, 1%deoxycholic acid, 0.1% 
SDS, and protease inhibitor cocktail (Roche)). Lysates were clarified by centrifugation at 
20,000XG for 30 minutes at 4°C. Clarified lysates were diluted 10-fold in binding buffer 
(50 mM Tris [pH 7.5], 300 mM NaCl, 1 mM PMSF, and protease inhibitors) then with 
100µL of 5 mg H3K4me3 peptide prebound to streptavidin agarose for 4 hr at 4°C. Beads 
were washed three times with binding buffer supplemented with 0.1% NP-40. Proteins 
were eluted in boiling SDS loading buffer, then run on a 9% SDS Page gel, and analyzed 
by western blot.    
PJH200 Assays 
10 μg each of MBP-RAG-1-myc-his (full length) and MBP-RAG-2 (wild-type or 
mutant, as indicated in the figures above), and 5 μg of pJH200 (Hesse et al. 1987). 
Plasmids were co-transfected into NIH3T3 cells in a 10 cm dish with TransIT-LT1 
(Mirus, Cat#MIR 2300) or Lipofectamine 20000 (Thermo Fisher, Cat#11668-019) per 
manufacturer’s protocol. Recombination efficiency was similar with both protocols 
(results not shown). After 48 hours, the cell pellet was divided into thirds, one for 
storage, one for DNA isolation, and one for protein extraction. Plasmid DNA was 
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extracted by a modified Hirt extraction per manufacturer’s protocol (Qiagen). 50 μg 
isolated DNA was transformed into 50 μL DH5α Max Efficiency cells (Thermo Fisher, 
Cat#18258012) per manufacturer’s protocol. 1.7% (5µL) of the transformation mixture 
was plated on LB agar containing 50 μg / mL ampicillin and the rest was plated on LB 
agar containing 50 μg / mL ampicillin and 15 μg / mL chloramphenicol. Plates containing 
ampicillin alone were scored after 16 hours at 37 °C, while plates with ampicillin and 
chloramphenicol were scored after 18 hours. 
Assays for DNA cleavage 
Coupled cleavage assays were performed as described (Lu et al., 2015).  
Equivalent amounts of active wild-type or mutant RAG tetramer (5µg) were incubated 
with 5 nM 32P-labeled HL44/45 substrate, 5 nM unlabeled HL46/47 substrate and varying 
amounts of H3K4me3 or H3K4me0 peptide in 10 µL reaction buffer (25 mM 3-(4-
Mopholino)propane sulfonic acid-KOH pH 7.0, 30mM KCl, 30 mM potassium 
glutamate, 5 mM CaCl2, 0.5 mM DTT, 0.1 mg/mL BSA, 1% glycerol).  After 20 min at 
37°C, MgCl2 was added to 5 mM and incubation was continued for 1 hr.  Reactions were 
stopped by addition of loading buffer (90% formamide, 0.2% bromophenol blue) and 
incubation at 90°C for 2 min. Products were separated on a 15% polyacrylamide-urea gel, 
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